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Chapter One

Introduction

1.1 Background and Project Motivation
Iron has long been recognized to play a key role in brain functions such as oxygen transport,
neurotransmitter synthesis, electron transfer, and myelin production [1, 2]. Despite the positive
implications, when in a free ferrous form, iron is known to be toxic and can lead to free radical
production. There has been a growing interest in studying the role of iron in neurodegenerative
diseases such as multiple sclerosis, Parkinson’s disease, Alzheimer’s disease and other
conditions including aging [1-6]. In healthy people, iron deposition in gray matter and white
matter structures evolves both temporally and spatially. It has been documented that iron content
in different brain gray-matter nuclei accumulates at different rates at different ages [7, 8]. It is
important to have the knowledge of quantitative characterization of brain iron change during
brain development and aging. This will allow us to gain more insights into the potential
abnormalities such as iron over-accumulation or iron deficit that involve in the pathophysiologic
process of various neurodegenerative diseases. Evaluating brain iron changes in normal brains in
vivo provides a reference for monitoring iron changes in patients both cross-sectionally and
longitudinally.
In the last few years, there has been an increasing interest in the role of veins in
neurodegenerative diseases, [9, 10]. More attention has been paid to the extracranial veins such
as the internal jugular veins (IJVs) and the azygous veins as being potential sources of venous
hypertension especially in multiple sclerosis (MS) [11, 12]. The obstructed veins are thought to
cause venous insufficiency. The use of MR angiography (MRA) and flow quantification (FQ) for
the study of the vasculature in patients with Parkinson’s disease is a novel concept spurred, in
part, by our recent work in MS patients [13].
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Idiopathic Parkinson's disease (IPD) is the second most common neurodegenerative disease and
the etiology of IPD remains unknown [14]. There are two interesting parallels between IPD and
MS to consider: both show reduced perfusion [15, 16], and both have regions of high iron
content in the basal ganglia [17, 18]. The parallels between the two diseases, the suggestion that
venous insufficiency causes damage to the vessel wall and leads to local extravasation of the
blood and subsequent increases in local iron content, and the presence of cerebrovascular disease
in roughly 39% of patients with IPD [19] led us to realize the importance to study the venous
vascular characters of IPD patients. This will have the potential to open new doors in studying
the vascular etiology of IPD.
Moreover, it has been shown that there is an increased presence of white matter hyper intensity
(WMH) in IPD patients [20]. The suggested causes for these deficits include ischemia and
venous insufficiency from periventricular venular collagenosis [21-23]. One group found that the
severity of WMH at baseline was the best predictor of PD progression [24]. This also motivates
us to study the correlation between WMH and venous abnormalities in IPD.
1.2 Project Aims:
In this dissertation, phase and quantitative susceptibility mapping (QSM) will be used for
measuring iron deposition in normal brain grey matter GM) nuclei to review the age effects, and
the correlation between susceptibility and in vivo iron concentration will be studied.
The head and neck major veins’ anatomy and blood flow in Parkinson’s patients will be studied
and compared with normal controls. White matter hyper intensity volume will be quantified for
Parkinson’s patients and compared with normal subjects.
Therefore, the specific aims and hypotheses of this thesis are:
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Specific Aim 1: To establish the baseline of putative iron content in the basal ganglia, mid-brain
and the thalamus as a function of age in healthy human brains using phase and ΔR2* on the basis
of susceptibility weighted imaging (SWI).
Hypothesis 1a: Phase and ΔR2* in the brain grey matter nuclei increase as a function of age.
Hypothesis 1b: The size of the high iron deposition region increases as a function of age in the
brain grey matter nuclei.
Specific Aim 2: To establish the baseline of iron deposition in the basal ganglia, mid-brain and
the thalamus as a function of age in healthy human brains using QSM derived from SWI phase,
and find the conversion factor between magnetic susceptibility and in vivo iron concentration.
Hypothesis 2a: Magnetic susceptibility in the grey matter nuclei increases as a function of age.
Hypothesis 2b: Linear correlation exists between susceptibility and in vivo iron deposition.
Specific Aim 3: To investigate the presence of structural and flow abnormalities in the dural
sinuses and extracranial draining veins in IPD patients and study the correlation between venous
abnormalities with WMH volume.
Hypothesis 3a: There is a higher prevalence of abnormal venous anatomy and flow on the left
side of the brain and neck in IPD patients.
Hypothesis 3b: WMH volume in patients with IPD is higher than in normal controls.
Hypothesis 3c: Venous abnormalities correlate with WMH volume.
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Chapter Two

Basic concepts of gradient echo imaging, phase, and
quantitative susceptibility mapping

Chapter overview
Gradient echo imaging (GRE) is one of the most important MRI sequence types. Rapidly
collecting high resolution MR imaging with low radio frequency (rf) power deposition becomes
possible with gradient echo-based MR imaging techniques [25]. In MRI, phase represents the
spatial magnetic field variations, and the magnetic susceptibility maps can be extracted from
phase image. Both the phase and magnetic susceptibility can be used for measuring iron owing to
iron’s paramagnetic character.
In this chapter, we will briefly introduce the basic aspects of gradient echo imaging that are
relevant to susceptibility weighted imaging (SWI). We will also touch on the principles of
susceptibility, phase and how to do quantitative susceptibility mapping from SWI phase images.

2.1 Gradient echo imaging
Larmor Frequency:
When placing a particle in a magnetic field, if the nuclear spin of that particle is not zero (in
multiples of ±1/2), the spin will precess around the external magnetic field axis. The precession
frequency is the Larmor frequency, which is defined as (we assume a right handed system) [25]
∙

(2.1)
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where ω is the precession angular frequency,

is the gyromagnetic ratio of the element, and

is

the actual field experienced by that particle.
Proton (hydrogen 1H) is the key element in the human body that produces nuclear magnetic
resonance signals owing to its non-zero net spin (1/2) and large biological abundance (around 63%
of the body weight [26]). Each type of element has its own gyromagnetic ratio. The
gyromagnetic ratio of the proton is 2.675×108 rad/s/T.
Magnetization Vector:
For a spin isochromat (a given small enough volume (V) whose external field is constant, so the
spins in V experience the same phase) with a large number of protons, by summing up all the
magnetic monument vectors and dividing by V, we get the magnetization vector (magnetic
moment per volume) [27]. The sum of the magnetization vectors is called net magnetization
( ). ;
When not taking the proton interactions into account, the Bloch equation is:

̂

where

2.2

is the strength of the applied magnetic field along z direction (longitudinal).

The magnetization can be decomposed into the longitudinal and transverse components:

0

̂

2.3

2.4
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Once the magnetization has a transverse component, it will rotate about B , and this can be
detected. An electromotive force (emf) is created in coil through with the spin’s magnetic flux
sweeps, a consequence of Faraday’s law. The time-dependent form of this current carries the
information that is eventually transformed into an image of the sample [27].

T1 Process:
In the external magnetic field, when doing nothing, the net magnetization (
same direction as the main field. So the longitudinal magnetization
transverse magnetization

) lies along the

is equal to

and the

is zero. After tipping the original net magnetization away from the

main magnetic field by using a radio frequency (rf) pulse, the longitudinal magnetization (

)

will gradually recover to the beginning state. The time which is used to describe this type of
longitudinal magnetization recovery is called the spin lattice relaxation time (T1), which can be
determined experimentally [27].
When taking the spin-lattice interaction into account, equation (2.3) becomes:
1
1

2.5

By solving the differential equation (2.5), after the application of an rf pulse, the longitudinal
magnetization can be calculated by:
0

/

1

/

2.6
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T2 process:
As mentioned in the “Larmor Frequency’ section, the transverse magnetization (

) rotates

about the main magnetic field z at the Larmor frequency. Due to the interactions between the
protons with their environment, spins at different locations may experience a slightly different
magnetic field which is the combinations of the main field and the local field [27]. This leads
those isochromats to rotate at different rates. As a result, the transverse magnetization starts to
dephase and the phase difference increases as time goes. Since the net magnetization is the
vector sum of each individual magnetization, during the dephasing process the transverse
magnetization decreases. The time constant which is used to describe the transverse dephasing
property (returning to transverse magnetization equilibrium,

0) is called the spin-spin

relaxation time (T2).
Therefore, the transverse component of the Bloch equation (2.4) should add another term for T2
decay:

̂

1
2

2.7

/

2.8

The solution for this differential equation is:
0

Both of the T1 and T2 processes occur at the same time. T2 is always less than or equal to T1.
There are basically two sources leading to the transverse magnetization decay. One is from the
molecular interactions which is described by T2, and the other is from the variations in

, which
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is described by T2'. The combined time constant is T2*. The relation between those time
constants is:
1
2∗

1
2

1
2′

2.9

The inversion of the relaxation times (T2, T2', T2*) are call relaxation rates (R2=1/T2, R2'=1/T2',
R2*=1/T2*). So,
2∗

2

2

2.10

The rule of thumb is that the magnetization loss due to T2' can be recovered in Spin Echo
sequence but not in Gradient Recalled Echo sequence (GRE), while the magnetization loss due
to T2 can’t be recovered no matter what sequence is applied.

Fourier transform MRI:
With the neglect of relaxation effects and demodulating frequency of
, , ,

, , ,

where

, ,

, , ,

is the effective spin density,

by the three orthogonal linear gradient fields G
,
, , ,
with

/2 , we define

∙∆

∙

,G
∙

, the MRI signal is

,

2.11

is the accumulated phase determined
, and G
∙

.
2.12
(2.13)
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′ ,

′ ,

′

(2.14)

Equation (2.11) becomes
,

,

∭

, ,

(2.15)

Therefore, by nature, the MRI signal is the Fourier transform of the effective spin density. The
MRI data are collected in k-space. Each k-space point is a complex number collected with real
and imaginary channels. Then by preforming the inverse Fourier transform to the complex kspace, the effective spin density distribution and phase can be reconstructed.

GRE sequence diagram:
After applying the excitation rf pulse, the transverse magnetization starts to dephase. There are
basically two ways to refocus the spins where an echo is formed. One way is to employ a π-pulse,
which is called spin echo; and the other way is to apply a dephasing gradient followed by a
rephasing gradient with the same amplitude and duration, which is called gradient echo.
Gradient echo imaging is one of the most important and frequently used sequences in modern
MRI. With the GRE technique, it becomes possible to collect MRI data rapidly with high spatial
resolution and low rf power deposition [25].
Figure 2.1 shows a typically 3D single-echo GRE sequence diagram. The corresponding k-space
trajectory for an example slice is shown in Figure 2.2. The data are being sampled (filling the kspace) when the ADC is on.
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Figure 2.1: 3D GRE pulse sequence diagram. rf = radio frequency, G = slab select gradient, G =
phase encoding gradient, G = readout gradient, ADC = analog to digital converter, TE = echo
/2.

time, T =sampling time.

In Figure 2.2, assuming the maximum amplitude of the phase encoding gradient G is G

,

increment of G between two continuous TRs is ∆G , the duration of each G is τ , at t

, the
t ,

according to Eq. (2.14), k and k of the first data point collected in k-space is

,

∙

∙

2.16

,

,

2.17
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k of other data points during T is
∙
At

, we have

∙
/2, so according to Eq. (2.18)

2.18
0, where a

gradient echo is formed. The time duration from the rf excitation to t is defined as echo time
(TE). The time duration between two successive rf pulses is called repetition time (TR). In the
example case shown in Figure 2.1, one k-space line is filled in each TR. During T , N points are
sampled symmetrically about k

0. By varying G and G , the whole 3D k-space will be filled.

Steady-state incoherent gradient echo imaging:
The sequence introduced in Figure 2.1 is a simplified GRE sequence. Practically, prior to the
application of the next rf pulse, the transverse magnetization left from the previous excitation
should be handled. We will consider only the spoiled gradient echo sequence in which the
remnant transverse magnetization is dephased at the end of each excitation cycle. This approach
leads to a lack of coherence in the transverse magnetization, and the longitudinal component is
the only coherence for the next excitation [28]. There are several methods to achieve spoiling,
such as by using variable high amplitude gradients (gradient spoiling), and/or by shifting the rf
pulse phase (usually the rotation angle is set to 117°) from one excitation to the next (rf spoiling)
[25].
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Figure 2.2: The corresponding k-space filling mechanism for a simple GRE sequence as shown
in Figure 2.1.

Magnetization equilibrium can be reached by repeating the application of rf pulses. For steadystate incoherent gradient echo imaging, the voxel signal can be written as [27]:

sin

1
1 cos

where ρ is the spin density of a given voxel,

/

,

,

（2.19）

, and

/

∗

.
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Sequence diagram of Susceptibility Weighted Imaging (SWI):
SWI is a type of 3D steady-state incoherent gradient echo imaging. Besides that, in order to
reduce the phase effect from blood flow, flow compensation gradients in the three encoding
directions are applied [25]. The single echo SWI sequence diagram is shown in Figure 2.3.

Figure 2.3: Single echo SWI sequence diagram. Flow compensation is in all three directions.
G = slab selection/partition encoding gradient, G = phase encoding gradient, G = readout
gradient.

2.2 Magnetic Susceptibility and Phase
Magnetic field and its perturbation due to substances inside the field
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When an external magnetic field passes through a substance, different substances will show
different macroscopic behaviors. Basically, the substance will get magnetized and the field inside
and outside will be perturbed. Magnetic susceptibility (χ) is the tissue property which describes
how the material is magnetized when exposed under a magnetic field and how the magnetic field
is changed by the material. Based on the induced magnetization, materials are categorized into
diamagnetic, paramagnetic and ferromagnetic materials [29]. The magnetic moment of a
diamagnetic material aligns anti-parallel to the main magnetic field (negative χ); the magnetic
moment of a paramagnetic material aligns parallel to the main field (positive χ ); and
ferromagnetic material creates its own magnetic field even without an external field (positive
constant magnetization M) [29].
Since the human body is mainly made of water by weight, susceptibility of water is used as a
reference which is approximately -9 parts per million (ppm) relative to vacuum. In this thesis,
when we say something being ‘diamagnetic’ or ‘paramagnetic’ actually means being more
diamagnetic or more paramagnetic than water. Iron is strongly paramagnetic, as a result it can be
easily detected with MRI.
A uniform magnetic field can be defined by
2.20
When an object is placed in this external uniform field, the magnetic field inside the material will
become
2.21
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where
(A/m),

is the magnetic field in Tesla,

is called magnetic field strength in Ampere/meter

is the magnetization either permanent or induced,

is the absolute permeability of the free space (4π
The induced magnetization

relates to

and

have the same unit, and μ

10 Tm/A).

by the magnetic susceptibility χ:
2.22

So by combing Eq. (2.21) and Eq. (2.22), the magnetic field inside the substance can be written
as (χ ≪ 1):

1

or

1

/

2.23

The magnetic field outside the substance will also be perturbed due to the induced magnetization.
The solution of the perturbed field depends on the induced magnetization and the shape and
volume of the object [25].
The magnetic field inside and outside a uniform sphere and an infinitely long cylinder has been
derived analytically, which are shown in Table 2.1 [25].
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Table 2.1: Expressions for field inside and outside a uniform sphere and an infinitely long
cylinder [25]
Internal Field

External Field

Sphere
3
Cylinder
6

∙ 3

1

2

∙

| |

∙

| |

∙ 3

∙ sin

1

2

In this table, B is the external uniform magnetic field applied along the z-direction. θ is the
angle between the position vector r and the main magnetic field for the sphere case, or between
the long axis of the cylinder and the main field for the cylinder case. ϕ is the polar angle
substanded by r on the plan perpendicular to the long axis of the cylinder. r is the position vector.
a is the radius of the sphere or the cylinder.

Phase
In MRI, phase is used to encode the special information. In the rotating frame, no phase
accumulation is seen. Phase from the encoding gradients is removed during signal modulation.
Thus, phase value at a given point in an MR image is sensitive to the local magnetic field
perturbation (∆

) relative to the main field [25]:
∆

∙

∙∆

∙

2.24

where TE is the echo time where the signal is acquired.
The phase image contains all the field information, macroscopic and microscopic. The
macroscopic fields come from the geometry of the big objects such as brain, air-tissue interface
around the sinus in the brain, and inhomogeneities in the main magnetic field. The microscopic
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fields are the ones we are usually interested in, the local susceptibility distribution [30]. Phase
can be summarized as:
∙ ∆
where ∆

∆

∆

∆

∙

2.25

represents the field variance due to chemical shift, which is different from the local

susceptibility effect. The local magnetic field variance generated from susceptibility difference
also depends on the geometry of the object, however, the chemical shift effect only depends on
the material type [31].
Phase aliasing
Phase images are reconstructed from the complex signals acquired through the real and
imaginary channels. The complex signal can be written as:
| |∙

∙

| |∙

∙

2.26

which can also be written as:
| | ∙

where |S|

̅,

is the magnitude and φ r, t

2.27

tan

is the phase (as shown in

Figure 2.4).
However, as shown in Figure 2.4, phase values can only be correctly returned if they are between
– π to π. If the phase value lies outside this interval, it will be wrapped back. For example, a
phase of 450° will wrap back to 90° This process is called phase aliasing. The true phase
can be described as:
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2 ∙
where

are integers. In order to obtain the actual information about ∆

2.28
,

needs to be

determined to unwrap the measured phase.

Figure 2.4: Complex representation of a signal vector S in the Real-Imaginary plane. |S|
represents the magnitude and φ is the phase.
Homodyne High Pass filter
According to Eq. (2.25), since our interest for iron quantification is the field change due to tissue
susceptibility, other terms relating to the global field inhomogeneity should be removed. Due to
the fact that the background field is relatively low spatial frequency in nature, it can be removed
by applying a high-pass filter. Homodyne high pass filter is a robust and efficient method for
background removal, which is widely used in SWI [32].
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When doing the homodyne high-pass filtering, low-pass filtered k-space data is created first by
applying a Hanning window to the central part of the k-space, and then reconstructing this low
special frequency k-space data to the image domain (ρ ). And then the original complex data (ρ)
is divided by the low-pass filtered data to generate the complex high-pass filtered image (ρ ).
The pipeline of the homodyne high pass filter processing is shown in Figure 2.5 [29]. The high
pass filtered phase image is generated by:
/

2.29

where the division is pixel-wised operation.
The advantages of homodyne high pass filter include that no phase unwrapping is needed; it’s a
very quick process, only about 10 seconds are need for processing a data set of 512×512×64; it’s
robust; it provides good contrast and high SNR. However, the homodyne high pass filter also
causes phase signal loss, especially for structures with relatively large sizes such as the globus
pallidus, putamen, thalamus and so forth. This will lead to an underestimation of the tissue
susceptibility which will further lead to errors for iron prediction [29].
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Figure 2.5: The illustration of the step flow to do homodyne high pass filter [29].
QSM reconstruction
creates dipolar field around it. The z-component of the field variation

Induced magnetization
can be written as [29]:

∆
̅

̅

4

3

̅′ ∙ ̅
| ̅
̅|

̅
̅
| ̅

̅|

2.30

which can be written as a convolution [29, 33]:
∆
where

is the 3D Green’s function:

∗

2.31
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∙
4
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2.32

From Eq. (2.23) and (2.31), the following equation can be generated which is used to predict the
induced magnetic field distribution from the magnetic susceptibility distribution:
∆

∗

∗

2.33

The convolution can be expressed in the Fourier domain, and the field variations will become:
∆

∙

∙

2.34

The Fourier transform of the Green’s function is:
1
3
0

,

0

,

0

2.35

Calculating the induced magnetic field distribution by the combination of Eq. (2.33), (2.34) and
(2.35) is call “Forward Calculation”.
Since ∆B

information can be extracted from phase images (φ

), χ

can be calculated

from the inverse calculation (rearrange Eq. 2.34):
∙
∙

∙

2.36
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Figure 2.6 shows the general steps of creating QSM maps.

Figure 2.6: Image processing procedures to generate susceptibility maps [29]. Phase unwrapping
is not necessary for all the algorithms before background field removal. For example, when
homodyne high pass filter is used to remove the background field, phase images don’t need to be
unwrapped before applying the filter. Phase unwrapping can be done with or without brain
binary mask images, but with the masks, the processing speed can be improved.
As we can see in Eq. (2.36),

goes to infinity when

is equal or close to zero,

which leads to an ill-posed problem. This happens at the points on or near two conical surfaces in
k-space at the magic angles of 54.7° and 125.3° from the B direction [34]. This problem causes
streaking artifact and high noise levels in QSM. This poor reconstruction behavior could be
solved through either truncated k-space division [35, 36] or other optimization methods [29, 34,
37].
In this chapter, we have introduced the basic aspects of gradient echo imaging that relevant
to susceptibility imaging, principles of phase imaging, phase image post processing and the link
between the magnetic susceptibility and phase information. Iron is the most abundant and a
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crucial metal element in human body [38]. It is a strong paramagnetic material. The presence of
iron can influence the magnitude and phase signals. As a result, iron can be visualized and
measured by MRI techniques. In the next chapter, we will review iron quantification methods.
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Chapter Three

Brain iron and iron quantification

Iron is the most abundant metal element within the brain [38]. People are becoming more
interested in understanding the roles of iron in brain normal functions and its association with
neurodegenerative diseases. It has been known that iron is involved in a variety of processes
which are vital for letting our brain function normally such as gene expression, neuronal
development, enzymatic reactions, dopamine, heme, iron-sulfur cluster synthesis, electron
transport and so forth [39]. Also, normal aging and the potential pathophysiology of many
neurological disorders are thought to have correlation with excessive iron accumulation or iron
deficiency [38]. For example, the iron elevation in the brain has been investigated extensively to
understand its link to neurodegenerative diseases including Alzheimer’s disease [40],
Parkinson’s disease [41], multiple sclerosis [18] and so forth. Iron deficiency has been reported
to be associated with developmental delays [42], attention deficit hyperactivity disorder (ADHD)
[43], restless legs syndrome [44] and neurodegeneration [45].
Approximately, 3 to 5 grams of iron is stored in healthy people [46]. There are basically two
categories of iron in the human body: heme iron which is in hemoglobin (two thirds of the total
iron) and non-heme iron (one third) [8]. Transferrin, ferritin and hemosiderin are three important
types of non-heme iron proteins. The function of transferrin is to carry iron from the blood to the
whole body and brain tissues. It can bind two iron atoms and its molecular weight is 79.6 kg/mol.
Ferritin is a soluble protein which stores excess iron atoms to maintain the homeostatic levels of
iron. Ferritin has a large spherical protein coat. There can be up to 4500 iron atoms in a 24-unit
ferritin molecule and the molecular weight is 474 kg/mol. Another form of iron storage protein is
hemosiderin, which is water insoluble and is considered coming from denatured ferritin and
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other material. It can be found in white blood cells and studies reported that relatively large
amount of hemosiderin is present in diseased brains [47].
3.1 Basic brain iron physiology
Normal Iron transport in human brain
Due to the presence of brain endothelium (blood-brain barrier or BBB), iron metabolism in
the brain is separated from other parts of the body. Although the mechanism of how iron crosses
BBB has not been completely understood, several pathways have been suggested. Those
pathways include transferrin / transferrin receptor (Tf/TfR), lactoferrin receptor / lactoferrin
(LfR/Lf) and GPI-anchored melanotransferrin / soluble melanotransferrin (MTf/sMTf) pathways
[48]. A pathway for the transport of non-transferrin-bound iron across the BBB cells also exists
[49]. Another suggestion is that ferroportin 1 (FP1)/hephaestin (Hp) and/or hephaestinindependent (FP1/CP) iron export systems might also plays roles in Fe

transport across

abluminal membrane of the BBB [48, 50].
Iron induced oxidative stress
Excessive iron deposition can be neurotoxic due to the possibility of generating induced free
radicals which contribute to the oxidative reactions [51]. Brain cells consume oxygen to
catabolize carbon- and hydrogen-rich molecules into energy. During this process, hydrogen
peroxide (H O ) is formed. Hydrogen peroxide can go across cell membranes freely. When
hydrogen peroxide reacts with ferrous (Fe
1893). The ferric (Fe

), the famous Fenton reaction happens (Fenton,

iron and highly reactive hydroxyl radicals are formed [51].
Fe

H O → Fe

HO

∙ OH
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These free radicals (∙ HO) will interact with polyunsaturated fatty acid (RH) and take an electron
from RH to produce another type of free radicals (R ∙).
RH ∙ HO → R ∙ H O
The organic free radicals (R ∙) may also react with oxygen to form organic oxygen radicals
(RO ∙)
R ∙ O → RO ∙
Then the oxygen radical will steal an electron from another lipid (RH) (it can be another
biological molecule) to form an organic hydroperoxide (ROOH) and another free radical (R ∙), so
the vicious cycle continues to damage the brain cells.
RO ∙ RH → ROOH

R∙

The damage chain is lipid peroxidation which can destroy lipids. In brain, the cell
membranes of neurons and many supporting cells are rich in polyunsaturated fatty acids, so they
are easily damaged by lipid peroxidation and can even lead to cell death [51].
Due to the high correlation of certain diseases with the problematic iron regulation,
researchers have been motivated to find robust and efficient methods to quantify iron in vivo,
which will provide better understanding of the normal iron behaviors and prognosis of disease
related to iron deficiency and overload.
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3.2 MRI methods for Iron quantification
Since iron in the form of ferritin is strongly paramagnetic and there is sufficient amount of
iron in the human brain, MRI signals (both magnitude and phase) can be related to iron
concentrations. Using MRI, we can image iron in the form of ferritin, hemosiderin and
deoxyhomoglobin. Moreover, tissue intrinsic parameters such as R2, R2*, magnetic
susceptibility can be extracted from MR images for iron quantification. The motivation for
quantifying iron is different for deoxhyhemoglobin, ferritin and hemosiderin. If we can quantify
the levels of deoxyhemoglobin in veins, then we can estimate the oxygen saturation [35]. This is
important in studying stroke, diseases with reduced perfusion such as multiple sclerosis (MS),
and cerebral vascular reserve. Quantifying ferritin may play a role in diseases such as
Parkinson’s disease, Huntington’s disease and a number of other diseases. Quantifying
hemosiderin is important in studying microbleeds with a particular interest in stroke [52],
dementia [53] and MS [54].
In this section, correlations between relaxation rates (R2, R2*, R2'), phase, magnetic
susceptibility (QSM) and absolute iron content (both in vivo and ex vivo) will be summarized. In
this thesis, the focus is on imaging iron in the form of ferritin.
R2 method
Local microscopic filed gradients (G) exist due to the presence of ferritin-loaded cells,
which lead to the diffuse movement of hydrogen protons [55]. The signal loss from this kind of
random movement won’t be recovered in spin echo sequence due to the stochastic nature of the
Brownian motion [55]. As a result, R2 values are affected by diffusion changes contributed from
iron [27]:
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2

2

2

3.1

where 2 is the biological relaxation rate which is determined by proton density, field strength,
temperature and so forth. 2

is the relaxation from diffusion, which is defined as:
2

/3 ∙ 

3.2

where γ is the gyromagnetic ratio of proton, G is the local microscopic gradient,

/ 2

which is related to the average step parameters (a spin moves step size of δ every τ second).
Since the presence of iron affects the local microscopic gradient G, therefore, iron effects can be
seen in R2.
R2 can be calculated by using multiple-echo spin echo sequence. Significant positive linear
correlations between R2 values and iron concentrations have been revealed in several studies
[55-58]. The correlation slopes reported by Langkammer et al and Mitsumori et al were 0.04 Hz
per µg Fe/g wet tissue and 0.057 Hz per µg Fe/g wet tissue. In Langkammer et al’s study, a 3T
magnet was used for scanning, and iron concentration was determined by inductively coupled
plasma mass spectrometry (ICPMS). In Mitsumori et al’s study, a 4.7T magnet was used and in
vivo iron concentration was estimated based on Hallgren & Sourander’s published iron-age
equations [7]. However, all the previous R2 studies measured

2

, which includes the

confounding term ( 2 ) for iron quantification. Therefore, this technique had several limitations.
First, because the diffusion effect from iron is subtle,

2

is not sensitive enough for

measuring iron content. Second, there are also several other factors could have impact on 2
through 2 such as water content, tissue composition, disease condition, formalin fixation [59]
and so forth. Also, R2 varies in magnetic field strength. All of those disadvantages suggest R2
correlates with iron content but it is not accurate enough to do iron quantification.
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R2* and R2' methods
R2* includes all the effects that can cause dephasing, which is defined as：
2∗

2

2

3.3

R2′ is attributed to all the microscopic, mesoscopic and macroscopic scale field gradients that
lead to static dephasing effects, which can be refocused in a spin echo sequence through the 180°
rf pulse but not with a gradient echo sequence. For a spherical object embedded in a
homogeneous tissue, R2′ can be written as [27]:

2

2
9√3

∆

3.4

where ∆χ is the magnetic susceptibility between the sphere and the background, B is the
uniform background magnetic field, η is the volume fraction. This equation shows the linear
behavior of R2′ on both volume fraction and change in susceptibility. For cylindrical objects, R2′
is also related to the angle.
The R2′ effect is much stronger than the iron induced diffusion effect embedded in R2.
Therefore, both R2* and R2' are more sensitive to iron content than R2 [55, 60]. R2* maps can
be generated from a multi-echo spoiled gradient echo sequence. R2* has been shown to be
linearly correlated with iron concentration [55, 61, 62]. The previous published R2*-iron
correlation slope is 0.27 Hz per µg Fe/g wet tissue according to an ex vivo study (3T, iron
concentration was measured with ICPMS) [55], and 0.114 Hz per µg Fe/g wet tissue from an in
vivo study (3T, iron content was estimated based on Hallgren & Sourander’s published iron-age
equations). A study from Yao et al [62] revealed positive linear correlations between R2* and
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iron concentration in three field strengths for both in vivo and in vitro data. The absolute R2*
values and the R2*-iron correlation slopes are different in each field strength with the highest in
7T and followed by 3T and 1.5T. They also showed that there is a nice correlation between iron
with R2* change rate (with respect to field strength). However, the results found from in vivo
and in vitro data were not consistent, which could be caused by formalin fixation.
Although R2* is much more sensitive to iron changes than R2, it still suffers the same
limitations as R2 because the baseline ( 2 ) term is also present in R2*. R2* is also affected by
magnetic field strength and the object angle as discussed.
depending on

2 offers the advantage of not

2 to measure iron content. However, comparing

2 with R2* to extract

2 accurately is a difficult procedure and is prone to many errors [63, 64]. Another limitation of
this technique comes from the signal loss due to the macroscopic susceptibility effects, which
makes measuring R2* in the cerebral cortex and surrounding nasal sinuses difficult [65]. The
artifacts due to susceptibility effects will be worse with long echo times and higher magnetic
field strengths. Such artifacts can be reduced with a higher-order shimming and higher image
resolution.
Phase
Another approach is using phase to estimate iron content [6, 66]. Phase values don’t depend
on intrinsic relaxation parameters but directly relate to the local magnetic field variations which
lead to the spatial distribution of the proton precession frequency.
∆ ∙

∙∆

∙

3.5

This method is very sensitive to small amounts of iron which induces changes of the magnetic
susceptibility and hence should be more accurate than the noisy T2 and T2* methods.
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However, other sources of phase shift also exist such as from magnetic field inhomogeneity
at tissue-air interface and imperfect shimming [65]. These shifts are large enough to affect the
entire phase image and have to be filtered. In addition, phase values can only be returned
correctly if it’s between – π to π, any degree beyond the range will be wrapped back to this range.
Thus, a proper algorithm is a critical step for phase processing. Moreover, another challenging
fact of using phase as an indicator of iron concentration is that besides the object susceptibility,
phase also depends on the geometry and orientation of the object [62]. As a result, it is more
difficult to localize and quantify iron deposition independent of geometry.
Quantitative susceptibility mapping (QSM)
QSM is the most modern MRI approach for estimating iron content. The QSM maps are
generated by using an inversion process on the phase images. The details of the theory and
processing steps have been introduced in Chapter 2.2. In theory, QSM approach is independent
of field strength, echo time, the relative orientation and the shape of the object [67]. The
correlations between susceptibility value and iron concentration have been summarized in Zheng
et al’s recent published paper [67] (Table 3.1). Other than the correlation slopes listed in Table
3.1, Lim et al just published a slope (0.73 ppb/µg iron/g wet tissue) for their new in vivo study.
However, the published in vivo susceptibility-iron correlations were determined from very
limited samples. And the way they quoted iron concentrations from the postmortem study [7]
were also questionable. The detailed discussion about this can be referred to Chapter 5.
Other MRI methods
The most popular ways of measuring iron with MRI have been reviewed. There are still some
other methods proposed to assess iron accumulation such as magnetic field correlation (MFC)
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[68] and direct saturation imaging (DSI) [69]. However, these are beyond the scope of this thesis,
so the details of those methods won’t be addressed here.
In the next chapter, a specific study of measuring putative iron using phase and ∆R2∗ in healthy
people will be presented.

Table 3.1: Correlation between susceptibility mapping and iron concentration [67].
Correlation
slope *

Structures

Background
removal

QSM method

Myelin
correction

Field
(Tesla)

Sample

Iron

Zheng et al.
(2013)

1.28~1.33

N.A.

Quadratic fitting

Forward
fitting

N.A.

3T

Ferritin

ICPMS

Zheng et al.
(2013)

0.83

GP,PUT,CN

SHARP

TKD (SO)

No

3T

Cadaver
brain

XRF

Haacke. (2012)

0.59

GP,PUT,CN

SHARP

TKD (SO)

No

3T

In vivo
brains

H&S

Shmueli et al.
(2009)

0.56

PUT,RN, SN

Polynomial
fitting

TKD (SO)

No

7T

In vivo
brain

H&S
**

Wharton et al.
(2010)

0.75/0.6

GP,SN,
RN,PUT,CN,TH,GM

Simulated
geometric
effect+fitting

TKD
(MO/TSO)

No

7T

In vivo
brains

H&S

Langkammer et
al. (2012)

0.89

GP,PUT, CN, TH

SHARP

HEIDI (SO)

No

3T

Non-fixed
Cadaver
brains

ICPMS

Schweser et al.
(2011)

1.30

GP, SN, DN,PUT, CN,
TH, WM,GM

SHARP

MO
regularization

Yes

3T

In vivo
brains

H&S

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

N.A.

Schenck (1992)
*

1.32 (1.27*)

The unit of the slope is 1ppb/µgFe /g wet tissue (=1.04g/ml at 36.5 ºC) for wet tissue; the unit for the ferritin solution is 1
ppb/µgFe/ml and the corresponding theoretical value is 1.27 ppb/ µgFe/ml.
**
H&S: (Hallgren and Sourander, 1958); SO: single orientation; MO: multiple orientation; TKD: thresholded k-space division.
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Chapter Four Correlation of putative iron content as represented by changes
in phase and R2* with age in deep gray matter nuclei of healthy adults
Introduction
In this chapter, both phase and ∆R2∗ methods for measuring iron in the brain will be considered. We
will specifically discuss the concept of two-region analysis where a given area of the brain is
broken up into low and high iron content areas. In the later section of this chapter, an application of
this iron quantification method is presented for normal controls.
Iron has long been recognized to play a key role in brain function such as oxygen transport,
neurotransmitter synthesis, electron transfer, and myelin production [1, 2]. Despite the positive
implications when in a free ferrous form, iron is known to be toxic and lead to free radical
production. Recently, there has been a renewed interest in the role of iron in neurodegenerative
diseases such as multiple sclerosis, Parkinson’s disease, Alzheimer’s disease and other conditions
including aging [1, 2, 47, 70, 71]. Due to the importance of iron in the human body, any iron
misregulation can be a major factor and can be used as a marker for neuronal death and other
pathological evidence in neurodegenerative diseases [72]. For instance, the disturbance of iron
metabolism can occur at several levels: iron uptake and release, storage, intracellular metabolism,
and regulation. However, the body has a number of ways to deal with this issue by storing excess
iron in the form of ferritin or hemosiderin. Ferritin appears to be the normal form of iron storage
while hemosiderin often appears when there has been bleeding and macrophages, and this fact can
be used to help consolidate the iron form [70, 73, 74].
Using methods such as diaminobenzidine acid enhanced Perl’s staining has revealed iron in many
cell types of the central nervous system, such as neurons, microglia, oligodendroglia, astrocytes and
in some myelin sheaths [75]. Iron is also found to be of higher concentration in gray matter (GM)
than in white matter (WM) [76]. Deep gray matter structures accumulate ferritin at different rates at
different ages [7, 75, 77]. It is believed and often quoted [7] that iron deposition increases quickly
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with age and then levels off or increases more slowly. Furthermore, it has been shown that there are
major iron deposits in the form of ferritin associated with the basal ganglia [78, 79]. The interest in
iron has led to attempts to quantify iron in vivo in neurodegenerative diseases in order to understand
their pathogenesis, monitor their progress and determine neuroprotective treatments.

Iron Quantification: previous approaches and SWI
A variety of methods have been proposed attempting to measure iron with magnetic resonance
imaging (MRI), including: T2, T2*, T2' [60, 80], field dependent relaxation rate increase (FDRI)
[81, 82], magnetic field correlation (MFC) [65] and susceptibility weighted imaging (SWI) [8].
Although R2 (or 1/T2) related methods using a spin echo sequence have been shown to be more
sensitive to GM/WM differentiation than R2', it has not been able to show clear specificity for iron
[80] in diseases such as Parkinsons because of confounding issues such as variable water content.
On the other hand, R2' has been shown to yield a good correlation with iron load, as R2' was seen
to increase for higher iron content structures. Individual T2 relaxation times showed more variation
after 45 years of age [83]. In R2' and R2* methods, R2' and R2* increased in GM but decreased in
WM as a function of age [84].
Recently, SWI [32, 85] has been used to measure or at least infer iron content in brain parenchyma
[8, 32, 86]. A recent comparison study between SWI and others sequences [12] confirmed that SWI
can be used as a tool to quantify iron deposition in the brain. Other studies [66, 87] have also tried
to probe brain iron with SWI by investigating the pattern of mineralization in the deep gray matter
as a function of age. To date, many researchers have looked at total iron content in specific regions
of the brain such as basal ganglia and thalamus, but no one has yet focused on establishing either
the regional changes of high iron content or how much iron content in this specific region changes
as a function of age.
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Iron quantification using gradient echo-based SWI data
In the following discussion, we focus on introducing the basic elements of iron quantification using
SWI in seven deep grey matter nuclei: caudate nucleus (CN), globus pallidus (GP), putamen (PUT),
pulvinar thalamus (PT), substantia nigra (SN), red nucleus (RN), and thalamus (THA). The regions
of interest (ROIs) are outlined manually based on their anatomical locations and the boundaries
shown in the high-pass filtered SWI phase images (Figure 4.1). These structures are measured
bilaterally.

Figure 4.1: Example boundaries are shown for: A) caudate nucleus, B) globus pallidus (black
arrow) and putamen (white arrow), C) red nucleus (black arrow) and substantia nigra (white arrow);
D) pulvinar thalamus, and E) thalamus.
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Drawing the ROIs:
One or more slices can be selected for analysis accordingly. The selected slices should show a welldefined border for the structures of interest. As a further condition, slices severely affected by sinus
artifacts cannot be used. The bright boundaries outside the structures are also avoided because this
large positive phase shift is most likely associated with the iron-induced dipolar field patterns in the
tissue [88]. Checking the boundary in adjacent slices is also necessary for making sure that the
traced boundary is right. If a single slice analysis is sufficient, then the selected slice should show
the largest area and agree with the above requirements.
Structures are zoomed by a factor of four to make the boundaries easier to determine and avoid the
iron-induced dipolar field. ROIs are drawn first on the phase images and then copied to the
magnitude images, this guarantees that the boundaries are exactly the same in both magnitude and
SWI filtered phase images.
Here are some criteria for slice selection of different structures if just a single slice is chosen for
analyzing each structure. Separate slices are chosen for the CN, the GP and the PUT respectively.
The slice for the PT is chosen to have the highest contrast on the phase images and to avoid the SN
or RN structures and the major veins. The RN and SN are drawn on the same slice that shows the
ring-like hyperintensity signal outside the RN , and shows no fusion of the SN and RN. For the
thalamus, the slice that clearly shows the boundary without showing the RN or subthalamic nucleus
is selected. Also, the internal capsule needs to be avoided while drawing the ROI around the
thalamus. Boundaries drawn for these structures are shown in Figure 4.1.

Phase units and SWI processing using SPIN
The ability to quote iron, say, in micrograms of iron per gram tissue (μg Fe/g tissue), depends on
associating a given phase value (preferably in radians) with an amount of iron. Each manufacturer
stores phase values in different ranges and even the same manufacturer can use different phase
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units from one version of software to another. For example, General Electric (GE) uses the range 3142 to 3142 to represent –π to π radians. One the other hand, Siemens Phase Unit (SPU) is the
scale used in Siemens MR Systems to represent phase information of the MR signal. This scale
ranges from 0 to 4096 which is equivalent to –π to π in radians.
For a right-handed system, 0 corresponds to –π, 2048 corresponds to 0, and 4096 corresponds to π.
On the other hand, for a left-handed system, 0 is π and 4096 is –π. If the scanner uses SPU,
observers need to know whether the scanner uses right or left hand system. One easy way to judge
which system the scanner uses is to check the veins and grey matter in the phase images (without
inversing). If they are hypo-intense (appear dark), then it is a right-handed system, whereas if they
appear hyperintense (bright), it is a left-handed system. In principle, in order to compare with other
systems, one should always convert the phase values into radians. (Another versions of Siemens
software is now using -4096 to 4096 and similar transformations must be considered to properly
record the phase in radians instead of these arbitrary units.)
After getting the magnitude and unfiltered phase images, SWI processing is done using SPIN
(Signal Processing in NMR, Detroit, MI, USA). The function is under Process>MIP/SWI
Processing>MIP with Phase Multiplications (SWI processing). Following the diagram, two sets of
images will be obtained: the high pass filtered phase images (HP) and the Minimum Intensity
Projection (MinIP) images. When the images are from a left-handed system, “positive” needs to be
selected, whereas if the images are from a right-handed system, choose “negative”. The high pass
filter is used to remove the low-spatial-frequency inhomogeneities caused by background fields and
air/tissue interfaces [89]. People usually use 64×64 or 32×32 as the filter size because these have
minimal effects on contrast for most small structures [1, 2, 90]. To obtain the MinIP images, a
phase mask f(x) is generated from the filtered phase image and used to create the fusion image,
SWI(x), by multiplying the magnitude image ρ(x) by the phase mask four times, that is: SWI(x) =
ρ(x)f4(x) [31].
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Two-region analysis:
Each structure can be seperated into two regions which contains high iron and low iron using
appropriate thresholds. The reason we analyze both a low iron content region (RI) and a high iron
content region (RII) is that an entire ROI analysis may reduce the sensitivity to more subtle changes
in iron content (Figure 4.2). The images are usually zoomed by a factor of 4 in the areas of interest
before starting preforming the two region analysis. To automatically separate these two regions,
thresholds related to phase for different structures are used according to literature [90]. The
thresholds are set using the measured mean value minus two times the standard deviation across an
elderly population (age range 55 to 85 years) to be on the conservative side as outlined in a study
by Haacke et al [90]. For pulvinar thalamus and thalamus which were not included in these papers,
we analyzed twenty normal cases which were randomly chosen from the subjects to get the mean
value and standard deviation. These phase thresholds mentioned above are from a right-handed
system data. For left-handed system data, the thresholds need to be adjusted by subtracting from
4096 SPU. Threshold values are shown in Table 4.1.

Figure 4.2: An example of a two-ROI analysis in the caudate nucleus. The low iron region is
denoted as RI and the high iron region as RII. The thalamostriate region is shown in A) and again
in B) with the smaller region being the high iron content region and the larger region being the total
region (RI + RII). The mean of the total region is 1989 SFU, while mean of RII is 1741 SFU. This
data is from a normal healthy volunteer.
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Table 4.1: Threshold values for the regional separation
CN

GP

PUT

PT

SN

RN

THA

Phase (rad, left-handed system)

0.190a

0.172a

0.330a

0.143b

0.356a

0.261a

0.049b

Phase (SPU) (left hand system)

2172a

2160a

2263a

2141b

2280a

2218a

2080b

Phase (SPU) (right hand system)

1924a

1936a

1833a

1955b

1816a

1878a

2016b

Magnitude (arbitrary unit)

117b

84b

112b

126b

90b

101b

118b

PUT: Putamen. CN: Caudate Nucleus. GP: Globus Pallidus. RN: Red Nucleus. PT: Pulvinar
Thalamus. SN: Substantia Nigra. THA: Thalamus.
a
Determined from [90]
b
Determined from 20 normal cases randomly selected from the sample
SPU = Siemens phase unit
rad = radian

For a right handed system, phase is given by
φ

γ ∙ ∆B ∙ TE

4.1

The choice of echo time is usually determined based on setting the phase of a vein parallel to the
main field being π [32]. This yields an echo time of 50ms at 1.5T for a hematocrit of 0.45 while
practically, to avoid aliasing, a slightly shorter echo time is chosen, typically 40ms. This value also
leads to a good R2* effect and phase effect for vessels perpendicular to the main field. Similarly,
20ms TE is used at 3T and 15ms at 4T and so forth, keeping the expected phase for a given
susceptibility constant as the field strength increases. In this case, B0TE is always 60T ∙ ms and the
phase images will look the same, except for the SNR of course. When the data are not collected
using such TEs, a factor (κ) can be used to “correct” either the measured phase or the thresholds
where
κ = (40/TE)(1.5/ B0)

(4.2)

As an example, consider a set of images collected at 1.5T with an echo time of 20ms instead of
40ms. In order to use the thresholds described above, one has to multiply the phase differences by a
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factor of κ = (40/TE)(1.5/ B0) = (40/20)(1.5/1.5) = 2. On the other hand, for the regional analysis,
one can also simply divide the threshold values by 2. An important point to remember is that after
high pass filtering, the phase of the white matter often has near zero value (or around 2048 in SPU).
This is because the WM dominates the low spatial frequency component of the image. To measure
the amount of iron, one measures the phase change between the white matter and the region of
interest or between the CSF and the region of interest. Although the latter is preferred since CSF
contains no iron, we used WM as the baseline because it is generally easier to measure and usually
appears as zero phase after filtering.
The conversion of phase from SPU to radian is (φ-2048)π/2048. The phase unit is also possible to
be converted to parts per million (ppm) field deviation via δ = Δφ/(5.09π) [90]. To convert from
SPU to µg Fe/g tissue, one can use
C

∆ /180

60

/

4.3

Eq. (4.3) is derived by taking 180 SPU as equivalent to the effect of 60 μg Fe/g tissue [90].
However, based on the results on ΔR2* changes, it is suggested that a phase change of 180 SPU
(0.276 rad) could represent as much as 240 μg Fe/g fresh tissue. If this number is used, and we
assume a density of 1g/cm3 for tissue, then the total iron would be calculated as follows:
C

∆ /180

240

/

4.4

In later part of this chapter, we will be showing iron content density expressed in four different
units for PUT, PT and SN (Figures 4.14 to 4.16).

∆R2* and iron content
The magnitude differences are related directly to iron via changes in R2* or ΔR2* [80, 84, 91]. If a
multi-echo SWI sequence is used, R2* could be calculated by taking the ratio of the magnitude
signal from two echoes to give:
∆

∙

∗

4.5
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We can find R2* that is proportional to the change of iron content from



1
S
ln( 2 )  R2 * ( Fe)
TE S1

(4.6)

Since only a single echo data set was collected (as has been the case here), by taking the average
magnitude signals of 10 patients with the lowest iron content as the baseline magnitude value (S0),
the iron content change relative to the lowest iron content patients can be calculated through the
ratio of the individual’s magnitude signal to the baseline magnitude, which yields:
∙∆

∗

4.7

where S1 is the signal from a given patient at any age and S0 is the baseline signal. Again, we can
find ΔR2* that is proportional to the change of iron content from
1
ln
TE

∆ 2∗

4.8

For the iron content predicted from magnitude signals, we suggest using 67/s for R2* or a
corresponding ΔR2* of 1mg Fe/g tissue [8].

Iron quantification: R2* versus Phase
As discussed in the introduction, both R2* and phase have been used to study iron in the brain [66].
Several studies where these two approaches (T2* and phase methods) were used showed good
agreement in some structures, but not such good agreement in other structures [60, 80, 92]. Which
approach is better likely depends on the amount of iron present and possibly some further
complications related to the mechanism of signal loss in T2* and the generation of phase for
microscopic structures. The manifestation of each is really quite different.
For large amounts of iron where strong dephasing across a voxel occur, changes in iron content will
cause signal loss and therefore a reduction in T2*. However, for smaller amounts of iron where
phase dephasing effects across a voxel are small, there may be little noticeable effect on T2* even
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in the presence of what could be physiologically a dangerously high level of iron. On the other
hand, phase is known to be very sensitive to subtle changes in magnetic field or frequency shift and
therefore is much more sensitive to iron in smaller concentrations. As the amount of iron increases,
phase and magnitude information start to correlate more strongly showing an almost linear
correlation. However, when the iron content is too large, phase aliasing occurs and the linear
correlation with phase may disappear. This problem may be avoidable by using a multi-echo SWI
sequence in the future and using the short echo data to unwrap the long echo data. From this
discussion, the following conclusion can be drawn: T2* underestimates iron content when the
amount of iron is small, whereas phase underestimates iron content if iron content is too high
(Figure 4.3).

Figure 4.3: A plot of phase iron versus magnitude iron for a series of 100 normal subjects. The
correlation is best when larger amount of iron is present. The values are plotted for Putamen in both
left and right hemispheres.
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Establishing a baseline for normal brain iron content as a function of age
To study iron as a function of age using SWI filtered phase and magnitude images, 100 healthy
adults (20-69 years; mean = 43 years) were evaluated using a single gradient echo SWI sequence.
The original magnitude and high pass filtered phase data (high pass filtered with a 64x64
homodyne filter) were used to evaluate iron content in the SN, RN, GP, PUT, CN, THA and PT.
Each structure was broken into two parts: a high iron content region and a low iron content region.
For all structures except the GP, we found an increase in putative iron content with age both for the
total region and for the high iron content region (Figure 4.4 - 4.12). In some cases, the rate of iron
deposition increased after the age of 40 years as evidenced in Figure 4.13 and Tables 4.2 and Table
4.3. In the figures that follow, we consider first the different measures of iron that were made: the
putative iron in the high iron content region, the average iron per voxel in the high iron content
region, the normalized area of the high iron content region, and the average iron (iron density) in
the total region. Figure 4.4 shows all four of these iron measures for both ∆R2∗ and phase for one
structure that best delineates the iron behavior in the putamen. Figures 4.5 and 4.6 show the
putative iron in the high iron content region for both magnitude and phase for the rest of the
structures. Figures 4.7 and 4.8 show the putative iron in the whole region for both magnitude and
phase. Figures 4.9 and 4.10 show the average iron in the total structure for both magnitude and
phase. Figures 4.11 and 4.12 show the normalized area of high iron content region as a function of
age for both magnitude and phase. The normalized percent area of high iron content region relative
to the total area was used to avoid the influence by the size change for a single structure between
individuals. Quantitative results for iron as a function of age for all the structures in terms of the
above eight measures are shown in Table 4.2.
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Figure 4.4: Putative iron measurement results as a function of age in Putamen. An increase in iron
content - represented here by the increase in phase and ΔR2* - with age for total iron, average iron
and the iron area are seen in the PUT. Stars and dashdot line are the values and fit of the right
hemisphere. Triangles and solid line are the values and fit of the left hemisphere. r2 is the
coefficient of determination. r2 is larger for the quadratic fit than just linear fit. L stands for the left
hemisphere. R stands for the right hemisphere. Quadratic relationships can be found in plots a, b, e,
and f representing the total iron in RII predicted from phase (a) and magnitude (b) and the area in
high iron region (phase (e) and magnitude (f)). This effect is not seen in the total region iron for the
whole structure (c, d, g, and h).
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- in
Figure 4.5: Putative iron content - represented here by
and ∆ 2∗
high iron content region in CN, PT, and THA where iron is seen to increase with age. Iron in CN
and PT shows quadratic relationship with age. Stars and dashdot line are the values and fit of the
right hemisphere. Triangles and solid line are the values and fit of the left hemisphere. r2 is the
coefficient of determination. L stands for the left hemisphere. R stands for the right hemisphere.
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- in
Figure 4.6: Putative iron content - represented here by
and ∆ 2∗
high iron content region in RN, SN, and GP. In all these structures, a significant increase with age
is seen. For GP, iron predicted from magnitude shows quadratic relationship with age. Stars and
dashdot line are the values and fit of the right hemisphere. Triangles and solid line are the values
and fit of the left hemisphere. r2 is the coefficient of determination. L stands for the left hemisphere.
R stands for the right hemisphere.
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Figure 4.7: Putative iron content - represented here by
and ∆ 2∗
- in
the whole region in CN, PT, and THA where iron is seen to increase with age. Putative iron in CN,
PT, and THA shows linear relationship with age. Stars and dash-dot line are the values and fit of
the right hemisphere. Triangles and solid line are the values and fit of the left hemisphere. r2 is the
coefficient of determination. L stands for the left hemisphere. R stands for the right hemisphere.
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Figure 4.8: Putative iron content - represented here by
and ∆ 2∗
- in
the whole region in RN, SN, and GP where iron is seen to increase with age except that in GP
represented by phase. Putative iron in RN, SN, and GP shows linear relationship with age. Stars
and dash-dot line are the values and fit of the right hemisphere. Triangles and solid line are the
values and fit of the left hemisphere. r2 is the coefficient of determination. L stands for the left
hemisphere. R stands for the right hemisphere.
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Figure 4.9: Average iron - represented here by average phase and ΔR2* - of the whole structure
as a function of age in CN, PT and THA. Stars and dash-dot line are the values and fit of the right
hemisphere. Triangles and solid line are the values and fit of the left hemisphere. r2 is the
coefficient of determination. L stands for the left hemisphere. R stands for the right hemisphere.
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Figure 4.10: Average iron - represented here by average phase and ΔR2* - of the whole structure
as a function of age in RN, SN and GP. Stars and dash-dot line are the values and fit of the right
hemisphere. Triangles and solid line are the values and fit of the left hemisphere. r2 is the
coefficient of determination. L stands for the left hemisphere. R stands for the right hemisphere.
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Figure 4.11. Normalized area of high iron content region as a function of age in CN, PT, and THA.
High iron content area in CN and PT show strong quadratic relationship with age (increase). Stars
and dashdot line are the values and fit of the right hemisphere. Triangles and solid line are the
values and fit of the left hemisphere. r2 is the coefficient of determination. L stands for the left
hemisphere. R stands for the right hemisphere.
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Figure 4.12: Normalized area of high iron content region as a function of age in RN, SN and
GP. High iron content area in RN shows significant linear relationship with age. Stars and dashdot
line are the values and fit of the right hemisphere. Triangles and solid line are the values and fit of
the left hemisphere. r2 is the coefficient of determination. L stands for the left hemisphere. R stands
for the right hemisphere.

Table 4.2: Slopes of phase and magnitude iron measures as a function of age in the two hemispheres
Age(yr.)

PUT
CN
GP
RN
PT
SN
THA

20-39
40-69
20-39
40-69
20-39
40-69
20-69
20-69
20-69
20-69

PUT
CN
GP
RN
PT
SN
THA

20-39
40-69
20-39
40-69
20-39
40-69
20-69
20-69
20-69
20-69

Left
0.16±0.08
2.07±0.52
0.79±0.32
2.00±0.33
-0.21±0.66
1.16±0.91
0.25±0.03
0.30±0.06
0.10±0.06
0.78±0.19

Slope
Right
0.27±0.11
2.21±0.63
0.64±0.34
1.35±0.29
-0.03±0.64
1.03±0.86
0.19±0.03
0.36±0.06
0.12±0.06
0.65±0.19

Total
0.21±0.07
2.14±0.41
0.71±0.23
1.68±0.22
-0.12±0.45
1.10±0.62
0.22±0.02
0.33±0.04
0.11±0.04
0.72±0.13

Iron-Magnitude-RII (sec1
×mm3/yr.)
Slope
Left
Right
Total
0.06±0.02 0.06±0.02 0.06±0.01
0.21±0.05 0.19±0.05 0.20±0.04
0.04±0.01 0.02±0.01 0.03±0.01
0.11±0.03 0.08±0.03 0.10±0.02
0.02±0.02 0.02±0.02 0.02±0.01
0.13±0.06 0.10±0.05 0.11±0.04
0.03±0.00 0.03±0.00 0.03±0.00
0.03±0.00 0.03±0.00 0.03±0.00
0.02±0.00 0.01±0.00 0.02±0.00
0.06±0.01 0.06±0.01 0.06±0.01

Iron-Phase-Total (rad×mm3/yr.)
Left
2.24±0.81
2.80±0.76
0.85±0.52
1.72±0.37
-0.20±0.75
0.36±0.68
0.55±0.07
0.31±0.08
0.19±0.12
0.67±0.28

Slope
Right
2.3±0.84
3.00±0.82
0.38±0.53
1.19±0.37
-0.38±0.68
0.08±0.62
0.56±0.07
0.32±0.08
0.20±0.12
0.70±0.27

Total
2.27±0.58
2.90±0.56
0.62±0.37
1.46±0.27
-0.29±0.50
0.22±0.46
0.56±0.05
0.31±0.08
0.19±0.08
0.69±0.19

Iron-Magnitude-Total (sec-1×mm3/yr.)
Left
0.11±0.04
0.14±0.04
0.06±0.02
0.09±0.02
0.07±0.06
0.10±0.05
0.03±0.01
0.02±0.00
0.02±0.01
0.10±0.02

Slope
Right
0.13±0.04
0.16±0.05
0.03±0.02
0.07±0.02
0.06±0.05
0.07±0.05
0.02±0.00
0.02±0.00
0.02±0.00
0.10±0.01

Total
0.12±0.03
0.15±0.03
0.04±0.02
0.08±0.02
0.07±0.04
0.09±0.04
0.02±0.00
0.02±0.00
0.02±0.00
0.10±0.01

Average iron-Phase-Total (10-3 rad/yr.)
Left
2.03±0.63
2.65±0.67
1.27±0.73
2.37±0.50
-0.07±0.69
-0.14±0.68
2.23±0.34
1.02±0.21
1.50±0.39
0.34±0.13

Slope
Right
2.03±0.65
2.60±0.67
0.79±0.78
1.77±0.54
-0.24±0.61
-0.10±0.61
2.19±0.33
1.09±0.22
1.43±0.37
0.35±0.13

Total
2.03±0.45
2.63±0.47
1.03±0.53
2.07±0.37
-0.16±0.46
-0.12±0.46
2.21±0.24
1.10±0.15
1.46±0.27
0.34±0.09

Average iron-Magnitude-Total
(10-3ms-1/yr.)
Slope
Left
Right
Total
0.10±0.03
0.10±0.03
0.10±0.02
0.15±0.04
0.14±0.04
0.14±0.03
0.07±0.03
0.06±0.03
0.06±0.02
0.12±0.02
0.09±0.03
0.10±0.02
0.07±0.05
0.07±0.04
0.07±0.03
0.07±0.05
0.07±0.05
0.07±0.03
0.13±0.01
0.12±0.01
0.13±0.01
0.07±0.01
0.08±0.01
0.08±0.01
0.07±0.01
0.07±0.01
0.07±0.01
0.05±0.01
0.05±0.01
0.05±0.00

Average iron-Phase-RII (10-3 rad/yr.)
Left
0.14±0.93
2.63±0.67
0.85±0.53
1.92±0.41
-0.29±0.94
1.89±1.57
0.97±0.18
0.51±0.09
0.31±0.21
0.62±0.08

Slope
Right
0.84±1.43
2.65±0.75
0.42±0.40
1.56±0.51
0.35±0.71
2.88±1.60
0.84±0.16
0.55±0.09
0.52±0.21
0.50±0.08

Total
0.49±0.85
2.64±0.50
0.64±0.33
1.74±0.33
0.03±0.59
2.39±1.11
0.91±0.12
0.53±0.07
0.41±0.15
0.56±0.06

Area-Phase-RII (10-3 %/yr.)
Left
0.33±0.17
3.97±1.01
4.21±1.72
8.75±1.50
-0.75±2.06
-0.03±1.50
3.02±0.52
4.40±0.80
0.71±0.42
1.92±0.72

PUT: Putamen. CN: Caudate Nucleus. GP: Globus Pallidus. RN: Red Nucleus. PT: Pulvinar Thalamus. SN: Substantia Nigra. THA: Thalamus

Slope
Right
0.56±0.22
3.76±1.29
3.51±1.95
6.01±1.48
-0.45±1.90
-0.65±1.38
2.14±0.44
5.64±0.85
0.76±0.42
1.72±0.71

Total
0.45±0.14
3.87±0.84
3.86±1.28
7.38±1.06
-0.6±1.39
-0.34±1.01
2.58±0.34
5.02±0.59
0.73±0.30
1.82±0.50
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Age(yr.)

Iron-Phase-RII (rad×mm3/yr.)

55

For PUT, CN, PT, and GP, the measures related to the high iron content region showed an
impressive quadratic relation with age (Figure 4.4a, 4.4b, 4.4e, 4.4f, 4.5a, 4.5b, 4.5d, 4.6f).
Generally, the results seemed to be fairly flat in the first two decades (20–40 years), but the local
iron content dramatically increased after 40 years of age. Increases occurred not only in the area of
the iron deposition but also in the average iron content. Fitting the data to two separate curves for
20–40 years old and 40–70 years old shows more clearly the dichotomous iron behavior in these
two age ranges (Figure 4.13). This rapid growth of iron build-up is not easily seen in the whole
structure iron analysis where only a linear relationship with age is seen (Figure 4.4g and h and
Figures 4.7–4.10).
The resultant iron deposition level changes depending on whether one examines the average iron
deposition in the whole structure, iron in the high iron content region (RII), or average iron in RII.
The order of the structures from the highest (scales as 1) to lowest (scale as 7) is shown in Table
4.3. All these changes may tell us something new and different about the iron deposition in each
structure. Comparing structures for both hemispheres, we found some phase- and magnitude related
measures of iron content showing significant differences between the two hemispheres. Most of the
time, the left hemisphere contains more iron than the right hemisphere (Tables 4.4 and 4.5).
Statistically, the PUT, CN, GP, and RN showed the largest effect. In addition, from Table 4.2, it
appears that the slope of the linear fit of these measurements in the left hemisphere was always
higher than that in the right hemisphere, except for the PT and the SN.
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Figure 4.13: Putative iron content in two age intervals - younger and older than 40 years old
subjects - giving a clear idea about iron deposition changes. Stars and dashdot line are the values
and fit of the right hemisphere. Triangles and solid line are the values and fit of the left hemisphere.
r2 is the coefficient of determination. L stands for the left hemisphere. R stands for the right
hemisphere.
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Table 4.3: The orders of high to low iron deposition over time.

Phase

Magnitude

PUT

RN

CN

PT

SN

GP

THA

Average iron (whole structure)

1

2

3

4

5

6

7

Iron in RII

1

6

2

5

7

3

4

Average iron in RII

1

4

3

6

7

2

5

Average iron (whole structure)

1

2

3

4

5

6

7

Iron in RII

1

5

3

5

6

2

4

Average iron in RII

3

2

4

5

6

1

7

Comparison between this study with some other studies
It is well known that iron deposition in the brain increases with age [7, 8, 66, 76, 93]. The work by
Hallgren and Sourander has been considered the standard reference for brain iron quantification [7],
which presents a wide belief that iron in the brain levels off after a certain age (30-40 years old) for
many structures. For instance, many studies have shown that iron level is low in newborn brain and
quickly increases during rapid brain growth which concurs with the peak of myelinogenesis [73]
until the age of 20 to 30, and then it reaches stable levels [7, 94]. However, this was not seen in all
brain structures. Hallgren’s and Sourander’s work showed that iron in the globus pallidus increased
until the age of 30 years old. Their results also suggest that the iron increase in the putamen and the
caudate nucleus is slow and reaches a maximum value around the age of 60 years old. On the other
hand, the iron level in the thalamus reaches its peak at the age of 30 years old, and then appears to
decline after that age. Recent studies used phase information to evaluate iron content in the brain
[66, 88, 95]. For instance, Xu et al. [66] showed that iron uptake remained age dependent in the
putamen, red nucleus and frontal white matter but not in the globus pallidus, substantia nigra and
caudate nucleus where, after a rapid increase in the first two decades, iron reaches a plateau.
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Putamen: Our results showed that iron content in the putamen remained age dependent throughout
5 decades and are in agreement with results of Xu et al [66]. This agrees with Hallgren’s and
Sourander’s work which showed that iron in the putamen was age dependent and did not reach its
maximum until the 6th decade, in agreement with a study by Aquino et al. [92] showing a slow rate
of increase and a variability after the age of 50. We found that both the volume of affected tissue
with high iron content and the average iron content per pixel increased with age, and in some cases
the rate of iron deposition are dramatically changed after the age of 40 years old in the following
structures: PUT, CN, GP and PT. This increase in iron may not be as rapid as that occurs in the first
two decades of life, but nevertheless is present in most people (Figure 4.13a, b and c).
Red nucleus: Our results showed that iron content in the red nucleus remained age dependent
throughout the 5 decades we studied and are in agreement with Xu et al.’s results [66]. However,
Hallgren and Sourander’s work showed a rapid increase in the first 2 decades (first 2 decades data
were not available in our study), whereas no conclusions were drawn regarding iron in the red
nucleus after the age of 20 due to technical difficulties.
Globus pallidus: In several studies [7, 78], iron in the globus pallidus was shown to increase
rapidly and level off after the age of 30 years old, whereas our results as well as Xu et al.’s [66]
show a linear decrease as a function of age. From Table 4.2 one can see that the iron concentration
in RII grows very fast with age, but the iron concentration in the whole structure grows more
slowly. As a result, we believe that the two region analysis is necessary for detecting more subtle
brain iron changes.
Substantia nigra: None of these studies (including our study) showed significant changes in SN
iron content as a function of age (Figure 4.16). However, the Hallgren and Sourander work showed
a rapid increase in the first 2 decades and inconclusive results for older ages, and Aquino et al. [92]
showed a rapid increase until the age of 15, and then the iron content reaches a plateau (note that
our study did not cover the age range from 0 to 19 years old). No correlation with our study can be
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drawn since the first two decades data were not available.
Caudate nucleus: According to Hallgren and Sourander, the iron in the caudate nucleus was seen to
behave in a similar fashion to the putamen, showing a slow increase reaching a maximum value at
age 60 years old. Xu et al [66]. showed that iron in the caudate nucleus increased slightly with age.
Both results contrast with our results as we see increases in iron content with age using the two
region-of-interest analysis. On the other hand, Aquino et al. [92] showed an almost flat iron content
with age. For the CN, we have found that iron increased slowly in the early ages, but this rate rises
dramatically after the age of 40 (Figure 4.5a, b).
Thalamus: According to Hallgren and Sourander, iron in the thalamus increased in the early stages,
reached a maximum at the age of 30, and then it started declining. Xu et al. showed that iron in the
thalamus is almost constant with respect to age. However, our results showed that iron in this
structure increases linearly with age (Figure 4.9e, f).
Pulvinar thalamus: The pulvinar thalamus has not yet been analyzed for its iron content in the
literature. Here, we show that the iron concentration in the PT increased linearly with age similar to
the rest of the basal ganglia and main body of the thalamus (Figure 4.15). The PT is of particular
interest in the study of multiple sclerosis where it appears as if major increases in iron content can
occur for subjects under the age of 40 years old.
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Figure 4.14: Expressing average iron content (iron density) in the PUT for RII and the whole
region with different units: µg Fe/g tissue, Siemens phase units (SPU), radians and ppm. The solid
triangles and squires are for the left and right side PUT for normal subjects. The dashed line and
solid line are the fits of the left and right PUT for normal subjects.
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Figure 4.15: Expressing average iron content (iron density) in the PT for RII and the whole region
with different units: µg Fe/g tissue, Siemens phase units (SPU), radians and ppm. The solid
triangles and squires are for the left and right side PUT for normal subjects. The dashed line and
solid line are the fits of the left and right PUT for normal subjects.

62

Figure 4.16: Expressing average iron content (iron density) in the SN for RII and the whole region
with different units: µg Fe/g tissue, Siemens phase units (SPU), radians and ppm. The solid
triangles and squires are for the left and right side PUT for normal subjects. The dashed line and
solid line are the fits of the left and right PUT for normal subjects.

Table 4.4: Comparison between the two hemispheres of phase related iron measures
Iron-Phase-RII

Average iron-Phase-RII

Number of
3

SD

L>R, L=R,

(rad×mm )

-3

(10

P
SD

value
rad)

3

SD

L>R,

(rad×mm )

-3

(10

SD

Number

rad)

P

Mean

value

-3

L>R,

value
L=R, L<R

L<R

Area-Phase-RII

Number of

Mean
P

Mean

L>R, L=R,

value
L<R

Average iron-Phase-Total

Number of

Number of

Mean
P

Mean

Iron-Phase-Total

P
SD

of L>R,

(10 %)

value
L=R, L<R

L=R, L<R

-3.18

19.14

40/14/46

0.09

2.11

44.43

49/16/35

0.64

-2.59

27.25

44/0/56

0.33

0.76

20.12

50/0/50

0.70

-0.77%

4.98%

41/14/45

0.12

CN

3.54

13.71

61/0/39

0.01

0.66

26.39

51/0/49

0.8

7.28

14.84

70/0/30

<0.01

7.19

19.26

59/5/36

<0.01

1.28%

6.56%

60/0/40

0.05

GP

0.87

26.76

54/0/46

0.75

-5.68

52.52

47/6/47

0.29

4.81

26.24

58/0/42

0.07

4.83

26.78

57/3/40

0.07

0.68%

5.99%

55/0/45

0.26

RN

1.13

3.19

60/18/22

<0.01

6.58

19.34

51/22/27

<0.01

0.73

5.18

55/0/45

0.16

5.56

25.95

59/1/40

0.03

1.67%

4.86%

56/20/24

<0.01

PT

-1.36

4.34

34/0/66

<0.01

-1.20

10.57

42/3/55

0.27

-1.06

5.90

40/0/60

0.08

-6.58

15.56

31/3/66

<0.01

-2.68%

6.60%

35/0/65

<0.01

SN

-0.89

5.76

35/10/55

0.12

-2.54

28.24

37/13/50

0.32

-3.24

10.13

40/0/60

<0.01

-6.21

33.18

45/1/54

0.07

-0.49%

3.82%

36/10/54

0.19

THA

0.65

12.20

53/0/47

0.61

0.13

6.76

40/8/52

0.86

-0.72

14.40

48/0/52

0.63

-0.44

7.06

39/8/53

0.55

-0.17%

4.04%

46/0/54

0.68

PUT: Putamen. CN: Caudate Nucleus. GP: Globus Pallidus. RN: Red Nucleus. PT: Pulvinar Thalamus. SN: Substantia Nigra. THA:
Thalamus
Mean: mean of the two hemispheres difference from left minus right hand side.
SD: standard deviation.
L>R: the amount of patients that show larger value in the left hemisphere. L=R: the amount of patients that show equal values in both
hemispheres. L<R: the amount of patients that show larger value in the right hemisphere.
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Table 4.5: Comparison between the two hemispheres of magnitude related iron measures
Iron-Magnitude-RII
Number of L>R,

Mean
-1

Average iron-Magnitude-RII

3

SD

(sec ×mm )

Mean
P value

L=R, L<R

-3

Iron-Magnitude-Total

Number of L>R,
-1

SD

(10 ms )

Mean
P value

L=R, L<R

-1

Average iron-Magnitude-Total

Number of L>R,
3

SD

(sec ×mm )

Mean
P value

L=R, L<R

-3

-1

Number of L>R,
SD

(10 ms )

P value
L=R, L<R

0.42

1.02

70/0/30

<0.01

0.07

0.68

50/14/36

0.3

0.51

1.23

70/0/30

<0.01

0.65

0.83

76/7/17

<0.01

CN

0.46

0.82

80/2/18

<0.01

0.17

0.48

55/20/25

<0.01

0.66

0.80

85/100

<0.01

0.81

0.93

83/100

<0.01

GP

0.29

1.13

60/5/35

0.01

0.04

1.60

51/16/33

0.81

0.57

1.41

70/0/30

<0.01

0.55

1.20

66/5/29

<0.01

RN

0.02

0.25

58/3/39

0.43

0.11

0.62

49/21/30

0.08

0.00

0.21

54/0/46

0.97

0.17

1.01

59/7/34

0.09

PT

0.04

0.30

47/4/49

0.23

-0.03

0.53

41/17/42

0.6

0.05

0.36

55/0/45

0.17

-0.03

0.79

44/9/47

0.76

SN

0.08

0.31

55/0/45

<0.01

0.18

0.83

48/19/33

0.03

0.20

0.54

68/0/32

<0.01

0.67

1.53

62/10/28

<0.01

THA

0.20

1.47

50/0/50

0.08

0.06

0.45

43/28/29

0.12

0.20

1.30

52/0/48

0.13

0.07

0.57

43/13/44

0.3

PUT: Putamen. CN: Caudate Nucleus. GP: Globus Pallidus. RN: Red Nucleus. PT: Pulvinar Thalamus. SN: Substantia Nigra. THA:
Thalamus
Mean: mean of the two hemispheres difference from left minus right hand side.
SD: standard deviation.
L>R: the amount of patients that show larger value in the left hemisphere. L=R: the amount of patients that show equal values in both
hemispheres. L<R: the amount of patients that show larger value in the right hemisphere.
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This study has a number of limitations. First, besides iron, there are also some other elements
that can contribute to phase changes such as calcium, magnesium, copper, and zinc. However,
they would tend to reduce the effects of iron. Also, we cannot separate these effects from those
of iron especially if these other elements are randomly mixed with the iron. Second, since there
was only a single gradient echo acquired, it was not possible to calculate an R2* map or to create
directly a ∆R2∗ map. Therefore, we had to assume that we could use the original signal from a
younger population as a means to normalize the data and create an effective ∆R2∗ map. These
variations might account for some of the spread of ∆R2∗ as a function of age. Although this
appears to have worked reasonably well, there can be problems associated with confounding
factors such rf coil loading, T1 values, and water content from person to person. Third, the
limitation on drawing further conclusions regarding the effects of iron changes with age comes
from the fact that the age range was only from 20 to 69 years. Including younger and older
subjects would have been of interest as well.
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Chapter Five

Assessing the changes of susceptibility in the human brain

nuclei over lifespan and investigating the correlation between susceptibility
and in vivo iron content
Introduction
Iron is the most abundant transition metal in the brain, and plays a key role in a number of brain
cellular processes including oxygen transport, electron transfer, neurotransmitter synthesis,
myelin production and mitochondrial function [2, 38]. However, the useful redox cycling
between ferrous (Fe2+) and ferric (Fe3+) iron can also make iron toxic when it is not safely bound
in ferritin, because free or poorly liganded Fe(II) can react with H2O2 to generate highly reactive
hydroxyl ions [96]. Both conditions of iron overload and iron deficiency (Hare et al., 2013) are
associated with human brain diseases. Elevated iron is often a feature of neurodegenerative
diseases such as multiple sclerosis (MS) [97], Alzheimer’s disease [98], Parkinson's disease [99],
Huntington’s disease [100], and ferritinopathies [101]. Histological in vitro analysis has
demonstrated iron accumulation rates in different gray matter (GM) structures are different
throughout an individual’s lifetime [7]. To further elucidate the involvement of iron in
neurodegenerative disorders, a robust in vivo quantitative non-invasive assessment of normal
brain iron deposition over time is essential. In this paper, we will attempt to provide such a
baseline that can be used to differentiate normal from abnormal iron levels in patients with
potential increases in iron content.
A variety of magnetic resonance imaging (MRI) methods have been used to quantify brain iron
including FDRI (field-dependent relaxation rate increase), R2, R2*, phase and quantitative
susceptibility mapping (QSM) [6, 55, 67, 82]. FDRI is a specific indicator for iron content, but it
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yields nosier data, longer scan times and lower spatial resolution. Although R2 has a linear
correlation with iron concentration [55], parameters generated from gradient echo sequences
(GRE) are more sensitive to the local susceptibility induced magnetic field inhomogeneity
caused by the presence of iron [102]. Magnetic susceptibility differences in brain tissues can
come from a variety of sources such as paramagnetic ferritin iron, blood, diamagnetic myelin
content, chemical exchange and fiber orientation [103]. Since the amount of myelin content is
negligible, it is currently assumed that the magnetic susceptibility of gray matter is dominated by
ferritin iron [7]. R2* has been shown to be a sensitive MRI parameter to estimate iron content in
deep gray matter [55]. However, besides iron, R2* is also affected by water content. For example,
in edema, signal from iron will be canceled out due to water's low R2* property. Also R2*
increases proportionally to the concentration of myelin. In contrast, iron and myelin content
manifest in opposite phase (field) behavior because the former is paramagnetic while the latter is
diamagnetic. This makes gray-white matter (GM-WM) contrast in phase and QSM superior than
that in R2*.
Phase has been used to represent iron content in the past [6, 90]. However, phase mapping
suffers from non-locality of the magnetic field distribution, so it does not provide accurate local
anatomical information [104]. This makes the estimation of iron content in 3D structures
impossible using phase images. In the last few years, QSM has been introduced to overcome the
non-local effects of phase and to provide the susceptibility maps [35, 105-107]. QSM is a postprocessing method which reconstructs source images directly from the phase images [33, 34].
Both post mortem [67, 108] and in vivo [82, 106, 107, 109] experiments have demonstrated
strong correlations between magnetic susceptibility assessed by QSM and known iron
concentrations of different structures in the brain [82]. However, the reported correlations were
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not consistent between the in vivo and in vitro results, and these in vivo studies had limited
sample size and age range.
To provide a measure of iron over a broad age range, we studied a group of 180 normal subjects
in vivo ranging in age from 20 years old to 69 years old by measuring the 3D structural magnetic
susceptibility of seven sub-cortical gray matter nuclei. Our goal is to produce a quantitative
magnetic susceptibility baseline as a function of age for each structure. These values will be used
to compare with the regional iron concentrations taken from the histochemical post mortem
study published by Hallgren and Sourander [7] to establish an in vivo quantitative conversion
factor between magnetic susceptibility and iron concentration.
Materials and Methods
Subjects
A total of 188 healthy subjects were enrolled and scanned at Dalian First Affiliated Hospital,
China. They were recruited from university staff, students and their relatives. Exclusion criteria
were history of neurological or psychiatric conditions, head trauma with loss of consciousness
for more than 5 min, drug and alcohol abuse, and brain surgery. These participants did not show
any focal parenchymal loss, infarction, resection, or large hyperintensities in their brain on T2weighted images. Seven subjects were excluded because of motion during scans. Two subjects
didn’t have their age recorded. Another four subjects weren’t included because certain interested
gray matter nuclei were lost after QSM processing. By excluding those cases, we included 175
normal subjects in this study (age, 45.1±14.2 years; range, 20-69 years; 86 females, 89 males). A
consent form approved by the hospital’s research ethics committee was provided for all
volunteers to read, understand, and sign.
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MR imaging
MR imaging of the brain was performed using a 1.5-Tesla (T) MR scanner (HD, General Electric
Co., Milwaukee, WI, USA) equipped with an eight-channel phased array head coil by using
identical protocols. The imaging plane was oriented parallel to the anterior-posterior
commissural (AC-PC) line. A three-dimensional gradient-echo sequence was applied to acquire
images for QSM reconstruction. The imaging parameters included: TR/TE = 53 ms/40 ms, flip
angle = 20°, slice thickness = 3 mm, bandwidth = 31.25 Hz/pixel, field-of-view (FOV) = 24 cm
and matrix size (Nx x Ny) = 384 x 320, yielding an in-plane resolution of 0.60 mm by 0.75 mm.
The total scan time was 6 minutes 28 seconds.
Image processing and Analysis
QSM images were reconstructed by using our in-house Matlab based toolbox SMART 2.0 (MRI
Institute for Biomedical Research, Detroit, MI, USA). Four steps were applied to generate the
resulting QSM images: : brain extraction (BET [110]), phase unwrapping (3D-SRNCP [111]),
background field removal (SHARP [106]) and an iterative QSM approach [34, 35]. The
magnitude images were used to extract the brain tissue. The original susceptibility maps were
derived by the following equation (for a right handed system) [35]:

1
1
3

where φ(r) is the phase distribution, TE is the echo time, B0 is the main magnetic field strength, γ
is the gyromagnetic ratio for hydrogen protons, kx, ky and kz are coordinates in k-space. The illposed nature from the denominator term, which is the Green’s function, was overcome by an
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iterative approach to obtain artifact free susceptibility maps [34]. An example resulting QSM
image and images from intermediate processing steps are shown in Figure 5.1.

Figure 5.1: Left: Original phase image. Middle: Phase image after performing brain extraction,
phase unwrapping and background removal. Right: Magnetic susceptibility map (iterative QSM
map). The three images are the same slice from the same case. In the susceptibility map, bright
signal intensities in the grey matter nuclei represent high magnetic susceptibility which relates to
high iron content.

Magnetic susceptibility values are relative, therefore the susceptibility measurements need to be
referenced to a particular region. The cerebrospinal fluid (CSF) is usually chosen as the reference
region [62, 112]. However, due to the fact that the CSF shows a large range of susceptibility
values [113], we quoted the values measured directly from the susceptibility maps in this study
to avoid the errors caused by reference selection. If white matter dominates the signal then these
will be susceptibility changes relative to white matter.
The susceptibility values in the regions of interest (ROIs) were assessed by segmenting these
structures manually based on their anatomical features in the susceptibility maps. To evaluate the
magnetic susceptibility of each nucleus in 3D, multiple slices were outlined to cover each entire
structure (Figure 5.2). The 3D ROIs were traced and analyzed using an in-house developed
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software SPIN (Signal Processing in NMR, MRI Institute for Biomedical Research, Detroit, MI,
USA). The gray matter nuclei assessed in this study included: Caudate Nucleus (CN), Globus
Pallidus (GP), Putamen (PUT), Thalamus (THA), Pulvinar Thalamus (PT), Red Nucleus (RN)
and Substantia Nigra (SN). Large blood vessels and the dark rims around the structures were
excluded when drawing the ROIs. Bilateral structures were traced on the same slices. The criteria
for defining these structures are as follows:
CN: The head of the CN will be included. The most superior slide is the one first shows the head
of CN. We omit the thin body part of CN because that part is vascularized, so it's hard to
distinguish whether the signal is from veins or iron. Also which 3mm thickness, the
susceptibility value of the thin body of CN is not trustable. The ROIs of the left and right CN
were drawn on 6-7 continuous slices until the structure vanished into the sinus.
PUT: Five to six continuous slices were outlined. PUT starts one slice lower than the CN.
GP: GP starts from 1-2 slices lower than the PUT and usually presents on 4 to 5 continuous
slices. It ends on the same level or one slice lower than the PUT. The slices with striations were
avoided.
RN: The circular shaped RN appears on 2 continuous slices, which is easy to identify.
SN: The contours of the SN were delineated on 3 continuous slices, which included the same
slices where the RN was drawn and the slice below RN.
THA: The THA was traced from inferior to superior. It starts from the 2nd slice above the SN
and continues for 4 slices.
PT: The ROI for the pulvinar thalamus was drawn on the same slices as the THA.
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Figure 5.2. Multi-slice 3D ROIs drawn on the QSM maps. Structures include: CN: caudate
nucleus (blue), GP: globus pallidus (green blue), PUT: putamen (orange), SN: substantia nigra
(yellow orange), RN: red nucleus (violet), PT: pulvinar thalamus (red), THA: thalamus (green).
Numbers on the images are the slice number of the data set. Each data set contain 40 slices.

To correlate the magnetic susceptibility with the iron concentration reported by Hallgren &
Sourander, the scatter plots of non-heam iron versus age in GP, PUT and THA were duplicated
electronically from a scanned version of Hallgren & Sourander’s paper by using
WebPlotDigitizer v2.6 (developed by Ankit Rohatgi). The reason to duplicate their data was to
match the subject age range when doing the comparisons.
Statistical analysis
The statistical analysis was performed using Microsoft Excel 2013 and Matlab R2012a
(Mathworks, Natick, MA). A p value of less than 0.05 was considered to be significant. The
susceptibility differences between left and right hemispheres in different structures of interest
were tested by paired t tests. Pearson correlation analysis was applied to investigate the relation
between susceptibility and age in each structure. A Pearson correlation coefficient larger than 0.5
was considered to be a strong relationship. Linear regression models were used to fit the data. In
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some structures, the susceptibility variance is not always homogeneous across age. The normal
subjects were separate into 5 groups on the basis of their age (each decade as a group). The
susceptibility means and standard deviations (SDs) were calculated.
To study the relationship between magnetic susceptibility and iron concentration, two methods
were used in our study. First, the iron concentrations published by Hallgren & Sourander in
scatter plots (GP, PUT and THA) were grouped into 5 bins (each decade as a group for subjects
from 21 to 70 years old) as we did for the susceptibility data. With those averages from matched
age groups, linear regression models were used to test the correlation between the iron
concentrations assessed with postmortem samples and the magnetic susceptibility. Another
method was by estimating the iron concentration in the PUT for each subject on the basis of age
by using the equation published in Hallgren & Sourander’s paper because the PUT shows the
best age dependency, and then linear regression was used to find the correlation between
susceptibility and the calculated iron concentration.
Results
Difference between two hemispheres and comparison between different gray matter nuclei
According to the paired t-tests, significant differences between the left and right hemispheres
were found in SN and THA for all the 5 decades. For other gray matter nuclei studied in this
paper, several age bins showed statistically differences (p<0.05). Table 5.1 shows the detailed
statistics of the hemisphere comparisons. The average magnetic susceptibility values of different
decades in the gray matter nuclei are as shown in Figure 5.3. The mean values and the SDs
plotted in Figure 5.3 were calculated by including all the left and right hand side measurements.
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Overall, the GP had the highest susceptibility, followed in decreasing iron content by the SN, RN,
PUT, CN, PT and THA.

Average susceptibility in each age interval
in different structures
Susceptibility (ppb)

200
GP

150

SN

100

RN
PUT

50

CN
0
21‐30 31‐40 41‐50 51‐60 61‐70
‐50

Age bins (year)

PT
THA

Figure 5.3: The average susceptibility for each of the 5 age intervals in different iron rich grey
matter nuclei. The error bars represent plus/minus 2xSD. Values were calculated by including
both of the left and right hemispheres. CN: caudate nucleus. GP: globus pallidus. PUT: putamen.
SN: substantia nigra. RN: red nucleus. PT: pulvinar thalamus. THA: thalamus.

Table 5.1. Statistics table of the susceptibility comparisons between the left and right hemispheres in difference intervals.
Decade

GP

PUT

SN

RN

PT

THA

29.69±5.97

129.34±21.47

30.91±8.87

90.08±24.74

46.34±20.01

29.51±8.16

3.19±4.87

31.09±7.06

124.42±18.57

31.90±9.38

79.91±20.84

43.90±19.42

25.25±9.02

-3.14±4.79

p

0.1532

0.0085

0.3358

0.0000

0.0445

0.0009

0.0000

Left (ppb)

35.37±10.37

129.03±23.60

42.76±12.65

107.85±27.45

70.40±25.60

38.83±13.84

2.38±5.72

35.17±10.00

127.21±21.05

44.21±11.99

94.81±24.67

68.63±24.36

35.70±13.38

-3.09±5.58

p

0.901563

0.3228

0.1402

0.0000

0.3844

0.0040

0.0000

Left (ppb)

35.73±9.72

147.66±29.20

54.89±12.67

113.5±32.16

99.99±22.40

43.37±18.14

2.9±6.61

39.59±7.83

147.71±30.61

56.44±13.70

104.45±31.47

99.70±28.23

43.82±19.32

-2.41±7.23

p

0.0090

0.9816

0.3084

0.0013

0.9126

0.8014

0.0002

Left (ppb)

41.77±10.49

143.62±29.83

63.82±17.40

114.01±32.81

94.67±26.02

39.39±12.42

-2.35±5.92

48.12±11.86

146.23±28.75

69.75±19.19

101.93±33.09

85.36±25.42

34.19±11.58

-8.48±5.44

p

0.0002

0.2753

0.0000

0.0000

0.0000

0.0001

0.0000

Left (ppb)

49.27±13.32

133.56±23.92

75.43±24.28

114.32±21.99

96.28±34.03

37.43±15.13

-1.97±6.66

49.13±14.83

133.07±21.20

70.72±22.22

101.84±22.69

91.50±27.88

34.39±19.44

-8.07±7.89

0.943329

0.854003

0.0039

0.0000

0.1113

0.1186

0.0006

Left (ppb)
21-30 yr Right (ppb)

31-40 yr Right (ppb)

41-50 yr Right (ppb)

51-60 yr Right (ppb)

61-70 yr Right (ppb)
p

Susceptibility values were quoted as Mean ± Standard deviation for each decade. Left: left hemisphere. Right: right hemisphere. p: p
value of the paired t tests. CN: caudate nucleus. GP: globus pallidus. PUT: putamen. SN: substantia nigra. RN: red nucleus. PT:
pulvinar thalamus. THA: thalamus.
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Linear relationship between susceptibility and age in iron rich deep gray matter nuclei
Figure 5.4 shows the susceptibility changes as a function of age in the gray matter nuclei
analyzed in this study. Except for the SN and THA, all other nuclei including the CN, GP, PUT,
RN and PT are plotted by combining the values from both hemispheres. The measurements of
the right SN and right THA are presented in Figure 5.4 because all 5 decades show statistical
difference between the two hemispheres in those two structures. The slopes and intercepts of the
fitted linear equations are summarized in Table 5.2. The Pearson correlation coefficients for each
relation are also listed in Table 5.2.
Table 5.2: The parameters of the linear fitting equations for Susceptibility vs. Age

CN

GP

PUT

SN

A (ppb/year)

B (ppb)

Pearson's Correlation Coefficient

Left

0.44±0.05

18.20±2.54

0.53±0.06

Right

0.50±0.06

18.24±2.65

0.56±0.06

Both

0.47±0.04

18.23±1.84

0.54±0.05

Left

0.24±0.14

126.10±6.76

0.13±0.08

Right

0.38±0.14

118.99±6.55

0.20±0.07

Both

0.26±0.08

122.45±3.92

0.17±0.05

Left

1.01±0.08

7.18±3.74

0.70±0.05

Right

1.14±0.08

3.94±3.95

0.72±0.05

Both

1.08±0.06

5.56±2.73

0.71±0.04

Left

0.52±0.16

84.71±7.34

0.25±0.08
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Right

0.47±0.15

75.31±7.07

0.24±0.08

Both

0.50±0.11

80.01±5.18

0.24±0.05

Left

1.25±0.15

25.11±6.91

0.55±0.06

Right

1.12±0.15

26.90±6.88

0.51±0.07

Both

1.19±0.10

26.00±4.88

0.53±0.05

Left

0.19±0.08

29.56±3.58

0.18±0.07

Right

0.18±0.08

26.67±3.92

0.16±008

Both

0.18±0.06

28.11±2.66

0.17±0.05

Left

-0.15±0.03

7.42±1.53

-0.33±0.07

Right

-0.16±0.03

2.31±1.57

-0.35±0.07

Both

-0.16±0.03

4.90±1.21

-0.31±0.05

RN (20-50 yr)

Both

2.42±0.17

-13.84±6.31

0.70±0.05

SN (20-50 yr)

Right

0.98±0.28

58.80±10.27

0.33±0.10

PT (20-50 yr)

Both

0.72±0.11

10.61±3.88

0.43±0.06

RN

PT

THA

Left: left hemisphere. Right: right hemisphere. Both: left and right hemisphere together. For RN,
SN and PT, data are also fitted for subjects between 20 and 50 years old.

In the PUT, CN and RN, the magnetic susceptibility appears to be linearly correlated with age
(R>0.5, p<0.05). The susceptibility distributions across ages are quite scattered in the GP, SN,
PT and THA with limited age dependency (R<0.3). According to the slopes, the susceptibility of
the RN shows the most rapid increase as a function of age with a changing rate of 1.19±0.10
ppb/year, and then followed by the PUT (1.08±0.06 ppb/year), SN (0.50±0.11 ppb/year), CN
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(0.47±0.04 ppb/year), GP (0.26±0.08 ppb/year) and PT (0.18±0.06 ppb/year). The THA shows
decreased susceptibility with age and with 0.16±0.03 ppb/year. Overall, it appears as if the
susceptibility values increase with an almost constant rate till around 50 years old and then level
off. By only fitting the data between 20 to 50 years, we found steeper slopes and better
correlations as shown in Table 5.2. Fittings of the data between 20 to 50 years for the RN and SN
are shown in Figure 5.4.
Correlation between susceptibility and iron concentration
For the data extracted from the scatter plots in Hallgren & Sourander’s paper, after excluding the
subjects younger than 20 years old and older than 70 years old, 47 subjects remained with an age
of 43.6 ± 14.2 years old. There is no age difference between our normal controls and those 47
subjects. Figure 5.5 shows the correlation between susceptibility measured by MRI in vivo and
iron concentration. The correlation slope is determined by linear regression. Two approaches
served to predict iron concentration as explained in the Methods section. By using the group
average approach (Figure 5.5 Left), we found χ

0.89

0.03 ∗ Fe

48.51

the equation based approach (Figure 5.5 Right), we found χ
59.49

4.09 . By using

0.93

0.05 ∗ Fe

6.43 . The correlation slopes investigated by the two methods are very close. The

method we applied for reconstructing susceptibility maps need to be corrected by a factor of 1.16
[67]. After correcting for this underestimate, the correlation slopes become 1.03±0.03 ppb per µg
iron/g wet tissue and 1.08±0.06 ppb per µg iron/g wet tissue for the two approaches, respectively.
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Figure 5.4: Magnetic susceptibility changes with age in different grey matter nuclei. The susceptibility values reported in this study
are highly consistent with Li et al.’s study [77]. Strong positive linear correlations are found in PUT, CN and RN. Mild positive linear
correlations are shown in GP, SN and PT and good negative linear correlation in THA. In RN, SN and PT, the linear correlations are
better if only looking at the data between 20 to 50 years old. PUT: putamen. CN: caudate nucleus. RN: red nucleus. GP: globus
pallidus. SN: substantia nigra. PT: pulvinar thalamus. THA: thalamus. Black circles: current study data. Blue dots: values published
by Li et al. from Duck University. Black line: linear regression fitting for the current study data. Red squares: average susceptibility of
each decade for current study. Vertical error bars: two standard deviations.
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Figure 5.5: Relationship between magnetic susceptibility and iron concentration determined
with linear regressions. Upper: It is estimated by correlating the bin averages of susceptibility
with matched bin averages of iron concentrations extracted from Hallgren & Sourander’s scatter
plots. The structures included in this plot are GP, PUT and THA because Hallgren & Sourander
only provided the scatter plots of those three structures which we also analyzed in our study.
Lower: It is estimated by correlating susceptibility with iron concentration calculated from ironage equation [7] in PUT, which shows the best age dependency. The correlations found with the
two methods are similar.

81

Discussion
Linear correlations between magnetic susceptibility and age were revealed in almost all the gray
matter nuclei studied in this manuscript (Figure 5.4). Some were strong such as in PUT, CN, RN
and THA, and some were weak such as in GP, SN, and PT. The strength of the correlation also
depended on what age range was used. Brain gray matter nuclei iron quantification with age has
been investigated with a number of methods such as R2* [61, 92, 114], phase [6, 66], and
histopathology [7]. Since our data included normal subjects from 20 to 70 years old, we
examined the susceptibility by comparing the same age range with other studies. R2* studies by
Aquino et al. (for PUT, CN, GP and SN) [92] and Li et al. (for PUT, CN, GP, SN and RN) [77]
reported exponential growth in R2* with age, which is consistent with the cadaveric study by
Hallgren & Sourander. However, after eliminating the young subjects (younger than 20 years old)
in those three studies, all correlations turn linear. The linear correlation between phase and age is
also found in some previous publications [6, 66]. The best linear age dependency is shown in the
PUT [6, 7, 61, 66, 77, 92, 114] and sometimes in the CN [6, 61, 77, 114] with R2*/phase/iron
growing well into the 80s. This is consistent with our susceptibility trends. Linear regression
curves in the GP [6, 7, 77, 92] and SN [6, 77, 92] are flat for R2*/phase/iron for subjects with
ages of 20 years and up; this is consistent with our findings. A detailed comparison between
studies is shown in Table 5.3.
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Table 5.3: Reported linear correlation between iron related parameters and age.
Structures Authors/Method

Linear correlation
(20 yr and up)

PUT

CN

Field
(Tesla)

Subject age Sample
range
size

Susceptibility/This study

Strong

1.5

20-69

175

R2*/Aquino et al. (2009)

Strong

1.5

1-80

80

R2*/Cherubini et al. (2009)

Strong

3

20-70

100

R2*/Peran et al. (2009)

Strong

3

20-41

30

∆R2*/Haacke et al. (2010)

Strong

1.5

20-69

100

R2*/Li et al. (2013)

Strong

3

7-83

174

Phase/Xu et al. (2008)

Strong

1.5

22-78

78

Phase/Haacke et al. (2010)

Strong

1.5

20-69

100

Susceptibility/Li et al(2013)

Strong

3

1-83

181

Cadaveric/Hallgren&
Sourander (1958)

Strong

Susceptibility/This study

Strong

1.5

20-69

175

R2*/Aquino et al. (2009)

Weak

1.5

1-80

80

R2*/Cherubini et al. (2009)

Good

3

20-70

100

R2*/Peran et al. (2009)

Strong

3

20-41

30

∆R2*/Haacke et al. (2010)

Strong

1.5

20-69

100

R2*/Li et al. (2013)

Strong

3

7-83

174

Phase/Xu et al. (2008)

Weak

1.5

22-78

78

Phase/Haacke et al. (2010)

Good

1.5

20-69

100

Susceptibility/Li et al(2013)

Weak

3

1-83

181

81

83

RN

GP

Susceptibility/This study

Strong

1.5

20-69

175

∆R2*/Haacke et al. (2010)

Strong

1.5

20-69

100

R2*/Li et al. (2013)

Weak

3

7-83

174

Phase/Xu et al. (2008)

Weak

1.5

22-78

78

Phase/Haacke et al. (2010)

Strong

1.5

20-69

100

Susceptibility/Li et al(2013)

No

3

1-83

181

Susceptibility/This study

No

1.5

20-69

175

R2*/Aquino et al. (2009)

Weak

1.5

1-80

80

No

3

20-41

30

∆R2*/Haacke et al. (2010)

Good

1.5

20-69

100

R2*/Li et al. (2013)

Weak

3

7-83

174

Phase/Xu et al. (2008)

Weak

1.5

22-78

78

No

1.5

20-69

100

Weak

3

1-83

181

R2*/Peran et al. (2009)

Phase/Haacke et al. (2010)
Susceptibility/Li et al(2013)
Cadaveric/Hallgren&
Sourander (1958)
SN

No

81

Susceptibility/This study

Weak

1.5

20-69

175

R2*/Aquino et al. (2009)

No

1.5

1-80

80

Good

1.5

20-69

100

R2*/Li et al. (2013)

No

3

7-83

174

Phase/Xu et al. (2008)

No

1.5

22-78

78

Good

1.5

20-69

100

No

3

1-83

181

∆R2*/Haacke et al. (2010)

Phase/Haacke et al. (2010)
Susceptibility/Li et al(2013)

84

PT

THA

Susceptibility/This study

No

1.5

20-69

175

∆R2*/Haacke et al. (2010)

Strong

1.5

20-69

100

Phase/Haacke et al. (2010)

Good

1.5

20-69

100

Susceptibility/This study

Week

1.5

20-69

175

R2*/Cherubini et al. (2009)

No

3

20-70

100

R2*/Peran et al. (2009)

No

3

20-41

30

Strong

1.5

20-69

100

No

1.5

22-78

78

Week

1.5

20-69

100

∆R2*/Haacke et al. (2010)
Phase/Xu et al. (2008)
Phase/Haacke et al. (2010)
Cadaveric/Hallgren&
Sourander (1958)

Good Negative
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Strong: R>0.5; Good: 0.3<R<0.5; Weak: 0.2<R<0.3; No: R<0.2.
R is the correlation coefficient.

To examine the stability and consistency characteristics of susceptibility mapping, we plotted the
susceptibility measurements from Li et al.’s study [77] on top of ours for subjects 20 years and
older (Figure 5.4). The plots clearly show consistency between the two studies. Although our
imaging parameters are different, it is encouraging to note that both approaches yield similar
results. This suggests that comparisons across different QSM algorithms, different types of
magnets and different centers is viable.
A negative relationship between the susceptibility with age was found in the thalamus in this
study. This is consistent with what Hallgren & Sourander reported in their postmortem work.
They claimed a rise in the iron content up to about 35 years old and then a decrease (although
they had a limited number of cases between 20 to 30 years). This trend is consistent with Bilgic
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et al.’s finding that the average susceptibility value in the thalamus was lower in the elderly
relative to the young [82]. Another comment we would like to make here is that the measured
susceptibility values are relative to that tissue which dominates the signal and established the
main frequency in the MR experiment and in this case that is the white matter. If the iron content
in the white matter goes up with age, then the downward trend we found here for the thalamus
would tend to flatten out in reality. This requires further study.
The correlation between magnetic susceptibility and iron concentration found in this manuscript
is 0.89±0.03 ppb/µg Fe/g wet tissue by the age bin method and 0.93±0.05 ppb/µg Fe/g wet tissue
by the iron-age function method [7] in PUT. The two slopes are close to each other. After
applying the correction factor (14%) due to the iterative QSM processing approach [67], the
slopes become 1.03±0.03 (0.89 / (1-14%) = 1.03) and 1.08±0.06 (0.93 / (1-14%) = 1.08) ppb/µg
Fe/g wet tissue, respectively. Those slopes are also very close to recent studies by Zheng et al.
[67] and Langkammer et al. [108]. In their studies, the susceptibility-iron correlation was
investigated by ferritin phantoms and cadaveric brains, and the iron concentrations were
measured by inductively coupled plasma mass spectrometry (ICPMS) and X-ray fluorescence
(XRF). The slopes reported were 1.11 ppb/µg Fe/g wet tissue (ferritin, ICPMS), 1.10 ppb/µg
Fe/g wet tissue (ferritin, XRF), 0.93 ppb/µg Fe/g wet tissue (cadaveric, XRF) and 0.96 ppb/µg
Fe/g wet tissue (cadaveric, ICPMS).
The consistency across sites in measuring iron with QSM suggests that this may be the best
approach to do iron quantification both in vivo and in vitro. Although R2* has been shown to
also correlate well with iron content, in either small or large amounts, it may not fare as well. For
example, for 3T magnetic, Langkammer et al. [55] reported a correlation slope of 0.27Hz/µg
iron/g wet tissue according to a postmortem study, while Peran et al. [61] and Yao et al. [62]
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reported the slope as 0.1142Hz/µg iron/g wet tissue and 0.120Hz/µg iron/g wet tissue
respectively with in vivo data. The differences slopes between studies may be caused by that R2*
depends not only on iron content but also on the water content and tissue composition. In
addition, R2* values will change as a function of field strength [62], while magnetic
susceptibility will always yield the pristine susceptibility, at least in theory.
Comparing the susceptibility values with iron concentration published by Hallgren & Sourander
is a popular approach to find the in vivo conversion factor. However, people always quote the
average iron concentration calculated from all 81 subjects with the age range of 31 to 100 years
for different gray matter nuclei [7]. This is not an appropriate way to find the correlation because
the average susceptibility values they had were not calculated from the subjects with the same
age distribution [106, 107, 109, 113] and the fact that iron deposition in gray matter nuclei
changes throughout the lifespan. Also, the sample sizes in those studies were small, only a few
cases were included. On the other hand, in this current manuscript, the average iron
concentration for each decade was calculated on the basis of Hallgren & Sourander’s scatter
plots. With this method, the age distributions are matched and more data points are used for
fitting (30 points), which ensures a more reliable conversion factor between the susceptibility
and iron concentration.
Another method proposed in this study to find the susceptibility-iron correlation is by estimating
the iron concentration from the age equations provided in Hallgren & Sourander’s paper [7]. The
disadvantage of this method is that there is no one to one match for each individual because the
equation can only represent the mean iron concentration throughout the lifespan. Because of this
we have to choose a structure which shows a strong age dependency. With the large sample size
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of 175 and strong age dependent characteristic in PUT, a reasonable quantitative correlation
between the magnetic susceptibility and iron content was seen.
Finally, we can make some comments about the potential susceptibility of the CSF thanks to the
strong linear relationship of susceptibility with iron between tissues. The intercepts
( 48.51

4.09 and 59.49

6.43 ppb) indicated by the linear fitting equations from the two

approaches can be used as an estimate of the susceptibility of the CSF. Since CSF is pure water
and doesn’t contain iron, it can serve as a baseline for estimating absolute iron deposition in
other brain structures. There are basically three regions that can be used to measure the CSF
susceptibility from the QSM maps: the body of the lateral ventricle, the ventricle next to the CN
and the CSF in the sulci in the upper brain. The body of the lateral ventricle contains choroid
plexus, so finding consistent values there was difficult. Also due to the filter size chosen for
SHARP processing is comparable to the sizes of gray matter nuclei and the body lateral ventricle
is such a big structure, the susceptibility will be potentially modified. The size of the CSF in the
sulcus is only a few pixels and sometimes veins pass through it.

Limitations
One of the limitations of this study is the lack of young subjects. However, by combining Li et
al.’s recent study [77], promising susceptibility trends with age are revealed in gray matter nuclei.
Another limitation is the lack of multi-echo data, so we couldn’t provide the comparison between
magnetic susceptibility and regional R2* in this study. However, in Li et al.’s in vivo study [77],
the correlation between R2* and susceptibility was suggested by a conversion slope of
0.1267Hz/ppb ( R2∗

0.1267χ ). As we have shown in Figure 5.4, our susceptibility
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measurements are comparable with theirs, so the susceptibility we measured can be converted to
R2* according to their calculations. In addition, Peran at al [61] published a correlation between
R2* and iron concentration for in vivo data with a slope of 0.1142Hz/µg iron/g wet tissue. In
Peran at el.’s work, iron concentrations were derived from published post-mortem data [7] in a
function of age. By combining the two relations, we have 0.1267χ
χ

0.1142 ∗ Fe, then

0.90 ∗ Fe

where shows by correlating our susceptibility measurements with R2* and then correlating with
iron on the basis of published correlations, the susceptibility/iron correlation is 0.90 ppb/µg Fe/g
wet tissue. This is very close to what we have found with our in vivo data: 0.89±0.03 ppb/µg
Fe/g wet tissue by the age bin method and 0.93±0.05 ppb/µg Fe/g wet tissue by the iron-age
function method (Hallgren and Sourander, 1958) in PUT.

Conclusion
The results of this study show that QSM is a reliable approach to do iron quantification and it is
independent of imaging parameters. Iron is directly correlated with magnetic susceptibility,
therefore, iron quantification can be done by QSM without the need for the postmortem iron
study by Hallgren and Sourander anymore. The susceptibility-age correlations revealed from the
175 normal subjects studied here can serve as a basis for determining normal iron content as a
function of age that can be used to help determine abnormal iron content levels in diseases that
affect iron content in the brain.
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Chapter Six Patterns of chronic venous insufficiency in the dural sinuses and
extracranial draining veins and their relationship with white matter
hyperintensities for patients with parkinson's disease
Introduction
Idiopathic Parkinson's disease (IPD) is the second most common neurodegenerative disease after
Alzheimer’s disease, and it affects roughly 0.1% to 0.3% of the population[14]. The main known
risk factor is age. The etiology of IPD remains unknown. Generally, Parkinson’s patients (PD)
show a loss of dopaminergic neurons in the substantia nigra pars compacta, a reduction of
dopamine levels in the striatum over time[115] and accumulation of intraneuronal inclusions
called Lewy bodies and Lewy neurites[116]. Although clinically PD is a motor disorder and has
a good response to dopaminergic therapy, in the advanced stages of PD most of the motor
disability symptoms don’t respond to dopaminergic therapy anymore[116]. There are also many
non-motor problems, such as cognitive impairment, autonomic dysfunction, neuropsychiatric
symptoms[117] and fatigue[118] for patients in both early and advanced stages. These findings
suggest the dopaminergic system may not be the only system involved in the PD process.
It has been shown that there is an increased presence of white matter hyperintensity (WMH) in
IPD patients[20]. The suggested causes for these deficits include ischemia and venous
insufficiency from periventricular venular collagenosis[21-23]. WMH might cause or exacerbate
motor or cognitive features of PD[119] especially in the presence of gray matter vascular lesions
involving the substantia nigra or striatum[120], corticostriatal-thalamocortical loop disruption,
damage to the interhemispheric connections of the corpus callosum[119], or disruption of the
subcortical afferents . If typical late-onset PD patients have a history of minor stroke, ischemic
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heart disease, or diabetes mellitus, they show more severe clinical features[121]. One group
found that the severity of WMH at baseline was the best predictor of PD progression[24].
In the last few years, there has been an increasing interest in the role of veins in
neurodegenerative diseases[12], and more attention has been paid to the extracranial veins such
as the internal jugular veins (IJVs) and the azygous veins as being potential sources of venous
hypertension[9, 11, 12]. Obstructed venous outflow in the extracranial veins was reported to
correlate significantly with hypoperfusion in the brain parenchyma which could contribute to
hypoxia and axonal damage[122, 123]. Additionally, venous hypertension in the dural sinuses
inhibits the absorption of CSF through arachnoid villi. Some studies showed an association
between the venous outflow disturbances with low net CSF flow in patients with MS[124, 125].
An important aspect of the venous abnormalities is that they are potentially treatable with
percutaneous transluminal angioplasty (PTA)[126]. The first application of PTA in the major
cerebral veins was done by Zamboni et al in 2009 in MS patients with CCSVI[127]. Since then,
a few studies have shown improvement in neurological outcomes and/or some quality-of-life
parameters in MS patients who underwent PTA[127-129].
The use of MR angiography (MRA) and phase contrast flow quantification (PCFQ) for the study
of the vasculature in patients with PD is a novel concept spurred, in part, by our recent work in
multiple sclerosis (MS) patients[13]. By applying flow encoding in the PC sequence, the
intensity of the phase images is directly proportional to the speed[130]. The phase intensity in
radians is then scaled to velocity using the relationship v=phase(Venc/π), in which Venc stands
for velocity encoding. By positioning these 2D PC-MRI flow slices roughly perpendicular to the
vessels in the neck, flow in all major vessels can be quantified. Using these morphologic and
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functional MRI techniques, we can not only obtain the anatomic vascular information but also
the quantitative arterial and venous blood flow.
To this end, we proposed this preliminary study with a group of 23 IPD patients to see if some of
these patients have abnormal structure or flow either intracranially and extracranially. The
outcomes from this study have the potential to open new doors in studying the vascular etiology
of IPD.

Methods
Recruitment of patients and controls
From May, 2011 to March, 2013, 40 IPD patients were recruited and scanned. Fifteen patients
did not receive a complete set of scans due to motion or termination because of patient
discomfort. Two IPD patients were excluded because they were scanned after taking medication.
By excluding those cases, we finally included 23 IPD cases and for this reason 23 age-matched
healthy subjects were included in this study. They were all recruited and imaged at Wuhan Union
Hospital, China. The patients with clinically definite IPD were diagnosed by a neurologist at
Wuhan Union Hospital based on the United Kingdom PD Society Brain Bank Criteria
(UKPDSBB). The patients and controls were imaged under internal review board approved
protocols.
Patients who fulfilled the UKPDSBB criteria were included. However, patients who had any of
the following conditions were excluded from this study: any element of the exclusion criteria
listed in UKPDSBB; patients with other neurological disorders such as Huntington's disease,
multiple sclerosis, normal pressure hydrocephalus; drug-induced Parkinsonism; hypoxia;
arteriosclerotic disease; hypertension or diabetes because excessive WMH may show in those
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patients. The following conditions were excluded for normal controls: history of cardiovascular,
neurological or psychiatric conditions; head trauma; hypertension; diabetes; drug or alcohol
problems.
All patients and controls consented to be subjects in this study. A 3T Siemens scanner with a 16
channel head/neck coil arrangement was used for acquiring the data (Siemens TRIO). Patients
underwent conventional clinical imaging as well as angiographic (arterial and venous) and flow
quantification imaging. The imaging parameters for each sequence are listed in Table 6.1. The
MRI images of the patients were acquired before taking medication.
Table 6.1: MR imaging parameters for different sequences.
T2-FLAIR
T2-FLAIR (2 PD patients,
2D TOF-MRV
(21 PD patients) 23 normal
controls)

SWI

PCFQ
at C6/C7

Transverse
Transverse
Sagittal
Transverse Transverse
Orientation
26
8500
6000
29
42.25
TR (ms)
5.02
93
396
20
4.13
TE (ms)
60°
130°
120°
15°
25°
Flip Angle
3
0.5x0.5x2.5
0.43x0.43x5
0.5x0.5x1
0.5x0.5x2 0.57x0.57x4
Resolution (mm )
217
287
781
119
531
Bandwidth (Hz/pixel)
An arterial saturation band with a width of 40mm and a separation of 10mm from the excited
slice was applied during 2D TOF-MRV acquisition. A maximum encoding velocity (VENC) of
50cm/sec was used for PCFQ.
Data processing and analysis
Data processing was done using our in-house software Signal Processing in Nuclear Magnetic
Resonance (SPIN, Detroit, Michigan). WMH were evaluated from the 2D FLAIR images. The
total volume of WMH was calculated semi-automatically by SPIN. As the FLAIR data were
collected with different resolutions, all the data were normalized to 1x1x5mm3 (transverse inplane) before doing the volume quantification. In addition, the MRI visual rating scale proposed
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by Scheltens et al.[131] was also used for evaluating the WMH level, which takes the number,
size and location of the WMH into account. The modified visual rating criteria are presented in
Appendix 1. The 2D TOF data were used for evaluating the venous structures in the head and
neck. A saturation band was applied to suppress the arterial flow in the 2D TOF images. The
maximum intensity projection (MIP) of the whole series was generated in the coronal view from
the 2D TOF coverage. The major veins of interest for the structural analysis included the
transverse sinuses and the extracranial veins in the neck.
The PCFQ images were used to analyze the through-plane blood flow in the lower neck (C6/C7).
Thirty time points were collected for each cardiac cycle. Cardiac gating was achieved using
pulse triggering. Background muscle was used to monitor the baseline to ensure there was no
bulk drift over time. We chose 50cm/sec as the Venc because this gave much better SNR for
venous flow than 100cm/sec, and flow in the arteries could still be unwrapped when aliasing
occurred, which was done automatically with SPIN. The vessels of interest included (Figure 6.1):
the internal and external jugular veins (IJVs, EJVs), vertebral veins, deep cervical veins,
common carotid arteries and vertebral arteries. The vessel lumen was segmented from the
magnitude images (Figures 6.1A and 6.1C) semi-automatically thanks to the presence of
sufficiently high contrast and copied onto the phase images (Figures 6.1B and 6.1D).
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Figure 6.1: PCFQ images without (A, B) and with (C, D) vessel contours used for blood flow
quantification. A and C are magnitude images. B and D are phase images. Vessels of interest for
this case include: internal jugular veins (solid down arrows), external jugular veins (up chevron
arrows), common carotid arteries (notched down arrows), and vertebral arteries (up solid arrows).
In this case, the right IJV has circulatory flow (blood flowing toward the brain) as shown by the
black arrow in the phase image.
The MR flow technique we use gives a pixel by pixel flow for each vessel. From each pixel we
get flow as a function of the cardiac cycle. From this data, for all vessels, we can obtain
integrated flow over the entire cardiac cycle (ml), volume flow rate (ml/sec) and both positive
and negative volume flow rates (ml/sec). The positive volume flow rate in the IJVs was used to
establish the criteria for circulatory flow. Circulatory flow represents the situation where there is
simultaneously positive and negative flow present within a vein. On the PC phase images, the
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vein with circulatory flow shows dark and bright signal areas (Figure 6.1D), and based on the
positive volume flow rate plot, the vein has at least 4 time points with positive flow higher than
2ml/sec and positive flow (toward the brain) present for at least half of the cardiac circle.
Example plots of the key parameters over a full cardiac cycle are shown in Figure 6.2. Figure
6.2A(3) shows the positive flow plot for an example with circulatory flow. The venous flow was
normalized by the total arterial flow (tA), which was defined as the sum of the flow in the
common carotid arteries and vertebral arteries. In addition, the ratio between the dominant and
sub-dominant IJVs (Fd/Fsd) was calculated. Dominant IJV represents the IJV which carries the
most outflow, and the sub-dominant IJV is the one with less outflow.
Based on the anatomic information from the 2D TOF and the quantitative IJV flow, the IPD
patients and normal controls were separated into 4 categories. Examples from each of these IJV
abnormalities are shown in Figure 6.3A-D. In defining the category types from a venous
anatomy and flow perspective, flow thresholds and cross section thresholds were defined. An
Fd/Fsd ratio greater than 4 was taken to be abnormal. We determined the Fd/Fsd threshold based
on the receiver operator characteristic (ROC) curve analysis of the patients and controls, and 4
represented the optimal cutoff to distinguish between the two populations. The work of Seoane et
al[132] suggested a factor of 3:1 for dominant to sub-dominant transverse sinus flow as a risk
factor. IJVs are continuation of transverse sinus, so our result is not inconsistent with their
findings. The threshold of normalized sub-dominant IJV flow (Fsd/tA) was calculated from the
normal controls by subtracting the standard deviation from the mean (0.24 – 0.10 = 0.14). An
IJV was called stenotic if the cross-sectional area was less than 12.5mm2 for the upper neck or
less than 25mm2 for the lower neck[13]. Based on these quantitative data and our general
observations, we considered the following four categories as representative of the data.
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Figure 6.2: A: Plots of the integrated flow (A(1)), volume flow rate (A(2)) and positive volume
flow rate (A(3)) of the vessels of interest over a full cardiac cycle at C6/C7 for the same case
shown in Figure 6.1. B: The same types of plots as shown in A but for a case without circulatory
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flow. Please note that comparing the positive volume flow rate between Case A and Case B, the
positive flow in the right IJV with circulatory flow (arrows in A(3)) is much higher IJV without
circulatory flow.
Category 1: All the following conditions must be met: 1) one or both transverse sinuses do not
appear on the TOF; 2) one or both sigmoid sinuses are not shown on the TOF; 3) absence or
local absence of IJVs on the TOF; 4) Fd/Fsd at C6/C7 is greater than 4 and Fsd/tA is less than 0.14,
or circulatory flow in one or both of the IJVs. In the example case shown in Figure 6.3A(2),
there is no left transverse sinus and no left sigmoid sinus on TOF. The upper left IJV is severely
stenotic (left arrow) and the top part is absent, and some other small veins reconstitute the left
IJV at the lower level. In this case, Fd/Fsd = 13.85.
Category 2: All the following conditions must be met: 1) one or both transverse sinuses do not
appear on the TOF; 2) sigmoid sinuses appear on the TOF; 3) there is banding in the IJVs (this
represents very slow blood flow) and/or the presence of stenosis along the IJVs; 4) same as
Category1 criteria(4). In the examples shown in Figure 6.3B(1), the left transverse sinus is
missing or invisible although the left sigmoid sinus is present. A banding artifact is evident in
almost the entire left IJV, which may be caused by an oscillatory or slow flow. The left sigmoid
sinus and the left IJV are much narrower than the right. The presence of a transverse sinus cannot
be ruled out without the use of a contrast agent, but there may be reduced flow that makes it
difficult to visualize with 2D TOF. Nevertheless, this slow flow may still be manifest in the
reduced flow visualized here. In this case, Fd/Fsd = 21.1.
Category 3: All the following conditions must be met: 1) sigmoid sinuses appear on the TOF; 2)
same as Category1 criteria(4). In the example case shown in Figure 6.3C, part of the left
transverse sinus appears to be missing due to slow flow or just in-plane flow, the left sigmoid
sinus is visible and Fd/Fsd = 4.39.
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Category 4: All the following conditions must be met: 1) the transverse sinuses and sigmoid
sinuses appear on the TOF; 2) the IJVs are not stenotic; and 3) Fd/Fsd at C6/C7 is less than 4 and
and Fsd/tA is bigger than 0.14. The Fd/Fsd of the example shown in Figure 6.3D is 2.1.
Except for category 4, all the other 3 categories contain some structural or flow abnormalities.
Categories 1, 2 and 3 are ranked based on the severity of the vascular structural abnormalities
with the abnormality in Category 1 being the most severe.

Figure 6.3: A-D: Example cases from each of four categories and different abnormal IJV
conditions shown in the coronal projection of the 2D TOF images. A: two cases from Category 1,
A(2) Fd/Fsd = 13.85. B: two cases from Category 2, B(1) Fd/Fsd = 21.1. C: A Category 3 case,
Fd/Fsd = 4.39. D: A Category 4 case, Fd/Fsd = 2.1. A(1): missing left IJV. A(2): stenotic left IJV
(white arrow in A(2)). B(1): banding artifact in the left IJV. The right IJV is big and the signal is
uniform, so the banding artifact in the left IJV is caused by abnormal flow, not by swallowing or
respiratory artifact. B(2): uneven signal contrast in the left IJV. Compared to the right IJV, the
signal in the left IJV is not uniform and has a stenosis (white arrow in B(2)).
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Statistical analysis
The optimal cut-off values for Fd/Fsd, WMH volume and WMH visual score to separate IPD
patients and controls were determined using a ROC analysis. An unpaired t-test was used to test
the difference between the two populations for age, tA, common carotid arterial flow, vertebral
arterial flow, normalized total IJV flow (tIJV/tA), normalized left IJV flow (LIJV/tA), Fd/Fsd,
normalized collateral venous flow, and WMH visual score. A paired t-test was applied to test the
difference between LIJV and RIJV. The categorization distribution difference between IPD
patients and the normal controls was analyzed by Chi-squared test. A Wilcoxon Rank-sum test
was used to test the WMH volume difference between patients and controls because of outliers.

Results
The age range of the IPD patients was 43 to 74 yr with a mean age of 62.6 yr and standard
deviation of 8.3 yr. For the normal subjects, the age range was 56 to 81 yr and the age mean was
64.1 yr with a standard deviation of 6.7 yr. There is no statistical age difference between the two
populations (p=0.48).
Category Analysis
The categorization distribution of the IPD patients along with the normal subjects using the
criteria defined above is shown in Figure 6.4A. Based on the venous anatomic characteristics and
asymmetric flow in the IJVs, there were clearly 4 categories with different severity of venous
vasculature. However, with a small number of subjects in some categories, the distribution
comparison between the patients and controls may not be applicable. We summed up the subject
number in categories 1 to 3 which represent the ones with both anatomic and/or flow
abnormalities and then did the comparison. For normal controls, 30% were in categories 1 to 3,
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and 70% in category 4; for the PD patients, 57% were in categories 1 to 3 and 43% belonged to
category 4. According to the Chi-squared analysis, these two populations are significantly
different (χ2=7.70, p < 0.01).
Quantitative Flow Analysis
The tA for the IPD patients and normal subjects were 14.67±2.49 ml/sec and 16.25±2.1 ml/sec,
respectively, and there was significant difference between them (p=0.04). The average flow in
the common carotid arteries was 5.98±1.26ml/sec in IPD patients and 6.51±1.12ml/sec in
controls. The blood flow in the common carotid artery was significantly larger (p=0.04) in the
normal people than in the IPD patients. The average flow in the vertebral arteries was
1.39±0.65ml/sec and 1.57±0.76 in the IPD patients and normal subjects, respectively, and there
was no significant between them. The tIJV and tIJV/tA for the normal controls was statistically
higher than the patients (IPD: 10.85±3.29ml/s, normal controls: 13.54±2.14ml/s, p<0.01; IPD:
0.74±0.17, normal controls: 0.84±0.14, p=0.03).
The normalized flow of the right IJV was found to be significantly larger than the left IJV for
both IPD patients (0.56±0.16 vs. 0.18±0.16, p<.0001) and the normal population (0.52±0.2 vs.
0.32±0.19, p=.01). The LIJV/tA was significantly higher in the normal controls (IPD: 0.18±0.16,
normal controls: 0.32±0.19, p=0.01). Another measure of flow variation between the left and
right IJVs is the ratio of the two IJVs, Fd/Fsd. Since Fsd can become quite small in some cases, we
restricted the ratio to be 10:1 when performing the average values so as not to skew the data (this
ratio was set to 10:1 for 8 PD patients and only 1 normal control). This ratio is significantly
larger in IPD patients than in normal controls (p =.04). Figure 6.4B shows the scatterplot of
dominant vs. sub-dominant IJV flow for the normal controls and IPD subjects.
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According to the four vascular categories we defined, Category 1 and Category 2 contain the
conditions of: IJV stenosis or missing IJVs, so we refer to patients in Category 1 and 2 as
stenotic patients and patients in Category 3 and 4 as non-stenotic patients. According to Figure
6.4B, the stenotic patients showed much higher Fd/Fsd than the non-stenotic patients. For the tIJV
and tA, there is no significant difference found between the stenotic and non-stenotic patients
(tIJV: 10.2±4.4ml/s vs. 11.3±2.4ml/s, p=0.52; tA: 14.7±4.4ml/s vs. 14.6±1.7ml/s, p=0.96).
The category type appears to correlate well with Fd/Fsd (Figure 6.4C), which indicates that the
higher the Fd/Fsd ratio, the more likely the patient sits in the severe abnormal structural and flow
categories.

Figure 6.4: A. Distribution of the IPD patients and normal controls according to the defined
categories. The normal population lies predominantly in category 4. Most IPD patients are
distributed in categories 1to 3 which have venous structural or flow abnormalities.
B. Scatter plot of dominant IJV vs. sub-dominant IJV flow at C6/C7 neck level in IPD patients
(circle) and normal controls (cross). The higher black line represents the Fd/Fsd=4:1. Comparing
to the normal subjects (5 out of 23 cases lie below the 4:1 ratio line), a higher percentage of the
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IPD patients (11 out of 23 cases: 48%) showed Fd/Fsd greater than 4:1. Moreover, all the patients
with stenosis in the IJVs (solid circles) lie below the line indicating that they have more severe
asymmetric flow in the IJVs. The lower black line represents Fd/Fsd=10:1. In this case, all but
only one stenotic PD case falls below the 10:1 line and only one normal falls below this line.
C: Scatterplot of category vs. Fd/Fsd for the 23 patients. They have good correlation (R2=0.72),
which indicates that patients with higher Fd/Fsd tend to be in the category with more severe
venous structural and flow problems.
Correlation between FLAIR WMH and categorization
Of the 23 IPD cases, 21 showed WMH. The mean, median and standard deviation of WMH
volume in IPD patients were 5827mm3, 502mm3 and 10755mm3 with a range of 0 mm3 to
42177mm3. The mean, median and standard deviation of the WMH volume in the normal
controls were 776mm3, 265mm3 and 1358mm3 with range of 0mm3 to 6147 mm3. There is a
significant difference between the two populations according to the Wilcoxon rank-sum test
(p=.04). The IPD patients and normal controls were further divided into a high WMH volume
group and a low WMH volume group. The threshold for this separation was set to 500mm3,
which was determined by an ROC analysis between the normal controls and PD patients. The
distribution of the patients and normal controls with high and low WMH volume along with the
category type is shown in Figure 6.5A.
The WMH visual score for the IPD patients was 5.8 ± 5.3, while the score of the age-matched
normal controls was 3.1 ± 3.0. There is significant difference between the two populations for
the WMH visual rating (p=0.05). Moreover, all the patients in Category 1 showed a WMH visual
score greater than or equal to 4. The distribution of patients with low WMH score (<=3) and high
WMH score (>=4) according to their categorization is shown in Figure 6.5B. We chose a score
of 3 as the threshold because it could best separate the patients’ categorization distribution.
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Figure 6.5: A: The distribution of IPD patients and normal controls with low WMH volume
(<500mm3) and high WMH volume (>=500mm3) for different categories. Majority of Category 4
patients and normal controls contain low WMH volume, while more of the patients in Categories
1 to 3 show high WMH volume. B: The distribution of IPD patients and normal controls with
low WMH visual score (<=3) and high WMH visual score (>=4) for different categories. All the
patients in Category 1 have high WMH visual scores. For patients in Categories 2 and 3, more of
the patients show high WMH scores.
Discussion
This paper is the first to study venous abnormalities on patients with IPD. The categorization
defined in this work could help distinguish IPD patients from normal controls: 70% of the
normal controls appeared in Category 4, while 57% of the IPD patients belonged to Category 1
through 3 (those containing venous structural and/or venous flow abnormalities). In addition,
those patients with higher WMH scores tended to be in Category 1 through 3, which indicates a
likely correlation between the vascular abnormalities and brain WMH. Moreover, 3 cases with
Fd/Fsd less than 4 and a WMH score higher than 4 showed circulatory flow in at least one of the
IJVs. The combination of structural abnormalities, asymmetric IJV flow, and abnormal
hemodynamics such as circulatory flow could together be a major risk factor for developing
WMH and perhaps even the disease itself.
Not all PD patients showed these flow abnormalities. However, PD is not a disease but a
syndrome and there may be many sources for its development. In this light, one may consider
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CCSVI to be just a co-morbidity associated with PD. As for the normal controls, there is
definitely an overlap with categories 1 through 3. If one used this to determine who might get PD
or neurodegenerative disease, normal controls seen these three categories would be incorrectly
assessed. But we have no way of telling today where they will sit 20 or 30 years from now.
Our finding of the asymmetric pattern of the IJV flow is consistent with many other research
publications since a majority of individuals are right dominant[133]. However, the flow ratio
between the two IJVs (Fd/Fsd) of IPD patients is significantly higher than the normal controls.
Moreover, patients with vascular stenosis have significantly higher Fd/Fsd than the non-stenotic
patients.
Recently, more attention has been paid to venous collaterals[134, 135]. By developing a model
to calculate the venous collateral flow, which is normalized to the tA, a collateral flow index
(CFI) has been compared between normal controls and MS patients with CCSVI. In the supine
position, the patient's CFI was reported to be significantly higher than the normal controls (61%,
p<0.0002)[134]. As our data was also collected in the supine position with quantitative flow in
the common carotids, vertebral arteries, IJVs and vertebral veins, a similar type of comparison
can be made between the IPD patients and the normal controls. In fact, we too found that the
normalized collateral flow in the IPD patients was statistically higher than in the normal controls
(0.26±0.17 vs. 0.16±0.14, p=0.03). One might well ask, “If the flow in the stenotic IJV and/or
transverse sinus can be recovered, could PTA be a potential therapy for some of these
patients?”[136, 137]
The observation of the original criteria established by Zamboni et al. [10] are not directly
observable by the methods which we have employed. While the original five CCSVI criteria
mainly concern flow and stenosis patterns at the lower neck level in the IJV and vertebral veins
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as well as the azygous vein, the observations which we have made constitute a new criteria
which has only been shown in MRI thus far[133]. Whether or not similar findings could be
made on ultrasound is unclear and needs further study, however given that a lack of venous
outflow and structural abnormalities have been observed using MRI in the transverse sinus and
IJV in our group of PD subjects the authors would expect that a similar observation would be
possible with ultrasound.
There are several different MRI visual rating scales for WMHs[131]. We chose Scheltens et al.
for this study because it is quite commonly used[138]. In addition, according to Pantoni et al’s
study[139], the four MRI rating scales referenced in their paper are well correlated. Although
having WMH is not a standard clinical diagnostic criterion for IPD, in this study cohort, 21
patients showed WMH, 5 had very high WMH volume (more than 10,000mm3) and of these 4
had a high visual score (greater than 9). A study did by Piccini et al.[20] found a positive
relationship between the WMH volume and PD symptom severity.
According to many in vivo imaging studies, 30% to 55% of PD patients show WMHs[140], and
some studies have suggested that WMH are more frequently present in patients with PD than in
normal elderly individuals and hypertension patients[20, 141]. Our finding that IPD patients have
higher WMH volume and visual score than normal controls is consistent with those studies.
WMHs may represent either lacunar infarcts or other tissue damage in the thalamocortial motor
system, a key area in the pathogenesis of Parkinsonian symptoms[115]. WMH are thought to
relate to cardiovascular disease[22]. Young et al.[23] reported the association between WMH
and loss of vascular integrity in a neuropathological study, which suggested a vascular origin for
these lesions. An MRI-pathological correlation study by Gao et al.[21] demonstrated that focal
and periventricular hyperintensities (PVH) often relate to venules and can increase or decrease
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over time. They proposed that venous collagenosis dilates the veins, making them macroscopic
and causing venous insufficiency with consequent vessel leakage and vasogenic edema[21].
These data support our findings where patients with venous structural and/or venous flow
problems are more likely to have more WMHs. Other factors could affect the WMH scores
besides venous abnormalities. However, it is believed that WMH especially in aging can be
caused by reductions in perfusion to the brain[142].
Limitations and future directions
There are a number of limitations to this study. First, the sample size is small. Nevertheless, even
with this small number, we found clear abnormal venous vascular characteristics in IPD patients
with significant differences from the normal subjects. This suggests that there is a prevalence of
vascular abnormalities in patients with IPD. With a larger number of patients, it would be
possible to study the correlation between the vascular problems with IPD sub-types. The second
limitation is the lack of 3D time-resolved contrast-enhanced arteriovenography (3D CE MRAV)
scans which could offer the advantage of acquiring separate arterial and venous phases and better
delineate the dural sinuses. Even though 2D TOF causes reduced signal from in-plane flow, for
patients with fast enough flow in the transverse sinuses (such as seen in many cases on the right
hand side), we still expect some signal representing the anatomy of the vessels. Third, collecting
flow in the transverse sinuses would also be useful to understand the fluid dynamics of the
evidently abnormal venous flow on the left side.

Conclusions
In this paper, we have shown several key findings. First, that WMH correlate with venous
jugular flow. And second, there are venous vascular abnormalities in patients with IPD that tend
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not to be present in the normal population. More specifically, we found that 90% of the patients
showed WMHs and that 57% of the patients had structural and/or venous flow abnormalities in
the transverse sinus, sigmoid sinus and IJVs. Nevertheless, this is a preliminary work and further
studies are required to confirm these conclusions. These findings may prove to be an important
imaging means to sub-classify IPD patients, to enhance our understanding of the etiology of IPD
and, perhaps, even lead to the development of new treatment regimens.
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Chapter Seven Conclusions and future directions

In this thesis, two topics were covered: one was quantifying brain iron and the other one was
imaging the vasculature characteristics in Parkinson’s patients using MRI. Two major projects
were included for the first topic (Chapter 4 and Chapter 5) and one major project (Chapter 6) was
done for the second topic. Three approaches were used for measuring iron: ∆R2∗ (Chapter 4),
phase (Chapter 4) and magnetic susceptibility (Chapter 5), which were all based on the SWI
sequence.
We investigated three MRI parameters’ (phase, ∆R2∗ and magnetic susceptibility) trajectories
over the lifespan in seven brain gray matter nuclei: caudate nucleus (CN), putamen (PUT),
globus pallidus (GP), red nucleus (RN), substantia nigra (SN), pulvinar thalamus (PT) and
thalamus (THA). Phase, ∆R2∗ and magnetic susceptibility increased as a function of age in most
of those structures, which suggested iron were accumulated in these structures as people getting
old since there is direct correlation between these three MRI parameters and iron concentration.
All the three parameters showed strong correlations with age in CN, PUT and RN. In GP, SN,
PT and THA, the correlations were relatively mild. One exception was the THA. Susceptibility
of THA decreased as a function of age. This was consistent with several previous studies [7, 82],
however, further studies are needed to warrant the correlation. The phase-age, ∆R2∗ -age and the
susceptibility-age correlations revealed from the normal subjects in Chapter 4 and Chapter 5 can
serve as a basis for determining the normal iron content as a function of age. The findings can
help determine abnormal iron content levels in diseases that affect iron content in the brain.
Besides the total ROIs, a more sensitive technique called two-region analysis was used to
evaluate iron content change over time in the phase and ∆R2∗ study. The high iron content
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region revealed two pieces of new information: both the average iron content per pixel and the
area of high iron (RII) increased with age. Furthermore, in the high iron region of PUT,
significant increase in iron uptake as a function of age was found for older adults past the age of
40.
QSM is a reliable approach to do iron quantification. It is independent of field strength, echo
time, the object's geometry and the relative orientation to the main field. Although different
centers may use different approaches to reconstruct susceptibility maps, the results are similar
according (Chapter 5). The stability and consistency characteristics of QSM makes it possible to
compare the quantification results across different types of magnets and different centers.
According to the susceptibility measurements shown in Chapter 5, the highest iron deposition
presents in the GP and then followed by the SN, RN, PUT, CN, PT and THA. The correlation
between magnetic susceptibility and in vivo iron concentration found in this chapter was
1.03±0.03 ppb/µg Fe/g wet tissue by the age bin method and 1.08±0.06 ppb/µg Fe/g wet tissue
by the iron-age function method in PUT. The two slopes were close to each other and also
comparable to other studies [67, 108].
Finally, we studied the patterns of chronic venous insufficiency in the dural sinuses and
extracranial draining veins and their relationship with white matter hyperintensities for patients
with Parkinson's disease. The IPD and normal subjects were classified using both the MR TOF
and PC images into four categories: 1) complete or local missing transverse sinus and internal
jugular veins (IJVs) on the TOF images; 2) low flow in the transverse sinus and stenotic IJVs; 3)
reduced flow in the IJVs; and 4) normal flow and no stenosis. When broken into the above 4
categories with categories 1 through 3 combined, a significant difference in the distribution of
the IPD patients and normal controls was observed. In IPD subjects, category type correlated
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with both flow abnormalities and WMH. From this preliminary study, we conclude that a major
fraction of IPD patients appear to have abnormal venous anatomy and flow on the left side of the
brain and neck and that the flow abnormalities appear to correlate with WMH volume.

Future directions:
High iron content region in the normal brain
Measuring iron using magnetic susceptibility is a continuation of using phase since the object
susceptibility is the source of phase signal, and it is free from the non-local geometry effect. As a
result, with QSM, it becomes possible to quantify iron in the 3D structures. In Chapter 5, we
analyzed iron in the whole structures which can serve as a baseline for determining normal iron
content as a function of age. However, to better understand the iron deposition pattern and to
evaluate iron in a more sensitive manner, we need to apply the two-region analysis technique to
the QSM data. This will be the next step of quantifying iron using magnetic susceptibility.
Magnetic susceptibility thresholds for separating the low iron (RI) and high iron (RII) regions
will be determined for each structure respectively, and for each structure, the thresholds are
calculated separately for each decade. The reason to do this is different structures contain
variable levels of iron content and iron deposition is age dependent. For each structure, a uniform
area will be selected on multiple slices, and the average susceptibility per pixel and the standard
deviation will be recorded. Then, a mean susceptibility value (Mean) will be calculated by
averaging the mean susceptibility of all the subjects in that decade. A mean standard deviation
(mSD) will be calculated by averaging the standard deviation of all the subjects in that decade.
The threshold of a given decade for a given structure is determined by Mean minus two times of
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the mSD (

2

). The pixels with susceptibility higher than this threshold is

defined as RII, which is the high iron content region since high susceptibility correlates with high
iron concentration.
The average susceptibility in RII and the normalized volume (normalized to the total volume of
the structure) of RII will be plotted as a function of age for each structure of interest. Those plots
can serve as a basis of determining abnormal RII iron deposition. The two-region analysis is
more sensitive to subtle iron changes comparing to the total ROI analysis which would average
out the local high iron deposition. Together with the total ROI baseline reported in Chapter 5, RII
iron baselines will provide valuable clinical information for the detection of abnormal brain iron
deposition in neurodegenerative diseases such as Parkinson’s disease, Alzheimer’s disease,
multiple sclerosis and so forth.
Dural sinuses abnormalities in PD patents
In Chapter 6, we studied the anatomical abnormalities in the dural sinuses of PD patients. Based
on the preliminary TOF data, we found that a fraction of PD patients show absence or partial
absence of transverse sinuses. This may be caused by the structural abnormalities or slow flow in
the transverse sinuses. Without CE-MRAV and PCFQ at the dural sinuses (including transverse
sinuses, sigmoid sinuses, straight sinus, superior sagittal sinus), it’s impossible to determine the
real causes. As a result, we are planning to preform CE-MRA and PCFQ to 50 IPD patients and
50 age and gender matched normal controls. For the anatomical MRAV analysis, arterial and
venous phases of the 3D CE MRAV will be identified. Images will be subtracted to separate
veins from arteries in order to identify any possible normal variants along the venous drainage
system or the presence of stenosis. The 3D data will be Mipped over many slices to get a better
overview of the drainage system. For the dural sinuses flow quantification, through-plane PCFQ
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will be performed for the superior sagittal sinus (SSS), the straight sinus and the both left and
right transverse sinus and sigmoid sinus. The anatomical features and the quantitative flow will
be compared between the IPD patients and the normal controls to verify our preliminary findings
in Chapter 6.
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APPENDIX A: MODIFIED VISUAL RATING SCALE FOR WMH
PROPOSED BY SCHELTENS ET AL [131, 139]
WMH in periventricular and deep white matter are scored separately as are the scores for
different lobes (the basal ganglia are also included in this assessment). The maximum score for
the former is 6 and the latter is 30 as outlined below. Note that the latter has five separate regions,
the frontal lobe, parietal lobe, occipital lobe, temporal lobe and basal ganglia.
Periventricular Hyperintensities (Minimum, 0; Maximum 6)


No caps in the occipital lobe ---- 0



Caps in the occipital lobe less or equal than 5mm ---- 1



Caps in the occipital lobe greater or equal than 6mm and less than 10mm ---- 2



No caps in the frontal lobe ---- 0



Caps in the frontal lobe less or equal than 5mm ---- 1



Caps in the frontal lobe greater or equal than 6mm and less than 10mm ---- 2



No bands at the lateral ventricles ---- 0



Bands at the lateral ventricles less or equal than 5mm ---- 1



Bands at the lateral ventricles greater or equal than 6mm and less than 10mm ---- 2

The same criteria is applied for the frontal lobe, parietal lobe, occipital lobe, temporal lobe and
basal ganglia
Deep White Matter Hyperintensities (Minimum, 0; Maximum, 30)


No lesion in the region being studied ---- 0



Number of the lesions less/equal than 5, size of the lesions less/equal than 3mm ---- 1



Number of the lesions more/equal than 6, size of the lesions less/equal than 3mm ---- 2
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Number of the lesions less/equal than 5, size of the lesions greater/equal than 4mm and
less/equal than 10mm ---- 3



Number of the lesions more/equal than 6, size of the lesions greater/equal than 4mm and
less/equal than 10mm ---- 4



At least one lesion larger than 11mm ---- 5



Lesions are confluent ---- 6
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ABSTRACT
MEASURING BRAIN IRON IN HEALTHY CONTROLS AND ASSESSING VENOUS
ABNORMALITIES IN PARKINSON’S DISEASE USING MRI
by
MANJU LIU
August 2014
Advisor: Dr. E. Mark Haacke
Major: Biomedical Engineering
Degree: Doctor of Philosophy
Iron plays a key role in a number of brain cellular processes. However, abnormal brain iron
regulation correlates with a number of neurodegenerative diseases such as Parkinson’s disease,
multiple sclerosis and so forth. To further elucidate the involvement of iron in neurodegenerative
disorders, a robust in vivo quantitative non-invasive assessment of normal brain iron deposition
over time is essential. A variety of magnetic resonance imaging (MRI) methods have been used
to quantify iron both in vivo and in vitro non-invasively. We first created the baseline of phase
value and ∆R2∗ as a function of age in seven gray matter nuclei. We also studied how the high
iron region in the structures change over time, which is a more sensitive way to study the brain
iron deposition. Quantitative susceptibility mapping (QSM) is another approch we used to study
normal brain iron deposition as a further step since susceptibility is a tissue property that is free
from geometry effect and imaging parameters. Except in the thalamus, iron increases over time
in the gray matter nuclei. We found iron content decreases as a function of age in thalamus
according to the susceptibility measurements. These measured susceptibility values are also
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compared with the regional iron concentrations taken from the histochemical post mortem study
published by Hallgren and Sourander to establish an in vivo quantitative conversion factor
between magnetic susceptibility and iron concentration. The correlation between the magnetic
susceptibility and iron concentration found in this thesis is 1.03±0.03 ppb per µg iron/g wet
tissue.
Idiopathic Parkinson's disease (IPD) remains one of those neurodegenerative diseases
where the cause remains unknown. Many clinically diagnosed cases of IPD are associated with
cerebrovascular disease and white matter hyperintensities (WMH). In this thesis, we also include
a study to investigate the presence of transverse sinus and extracranial venous abnormalities in
IPD patients and their relationship with brain WMH. As a result of this preliminary study, we
conclude that a major fraction of IPD patients appear to have abnormal venous anatomy and flow
on the left side of the brain and neck and that the flow abnormalities appear to correlate with
WMH volume.
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